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ABSTRACT 
 
A multitude of organs play a critical role in managing metabolism including 
the liver, pancreas, gut, brain, muscle, and adipose tissue. Abnormal function in 
any one of these can offset the metabolic balance and negatively affect whole body 
function thereby contributing to the development of metabolic complications and 
obesity. Although no single metabolic abnormality is responsible for obesity, 
understanding how normal cellular processes are regulated provides us with 
knowledge to reverse them during times of dysfunction. The main focus of this 
dissertation is on the regulation of adipose tissue due to its dual role of storing 
excess lipids and endocrine organ capabilities. Adipocytes, along with a majority 
of other cell types, are highly dependent on calcium (Ca2+), thus the role of Ca2+ 
and the involvement of the Ca2+ channel Transient Receptor Potential Canonical 
1 (TRPC1) were studied. The evidence provided in this dissertation shows that 
Ca2+ entry in adipocytes, especially upon store-depletion, plays an important role 
in adipocyte differentiation, autophagy, and adipokine secretion and subsequently 
metabolic regulation. The endogenous Ca2+ entry channel in both subcutaneous 
and visceral adipocytes was found to be dependent on TRPC1-STIM1 complexes 
and altering or blocking TRPC1 resulted in dysfunctional adipocytes.  
 Adipocyte differentiation, the process of pre-adipocytes converting to 
adipocytes, is a tightly regulated process with Ca2+ dependency. Blockage of 
xvi 
 
TRPC1-mediated Ca2+ entry with SKF-96365 inhibited differentiation which was 
indicated by decreased lipid accumulation and expression of PPARg, FAPB4, and 
perilipin in both subcutaneous adipose tissue (Subc AT) and visceral adipose tissue 
(VAT). Loss of TRPC1 in either adipose tissue type resulted in a reduced ability to 
differentiate which occurred prior to PPARg expression indicating TRPC1-mediated 
Ca2+ entry is necessary for the initial stages of differentiation.  
 Diets high in fat induce unhealthy expansion of adipose tissue, while exercise 
reduces adipocyte size and lipid content. Mice deficient of TRPC1 function and 
challenged with both a high-fat diet and exercise had lower fat mass and fasting 
glucose concentrations along with decreased adipocyte numbers. Further investigation 
indicated a decrease in autophagy with a concurrent increase in apoptosis. Together, 
this data shows that TRPC1 inhibits the positive effects of exercise under a high-fat 
diet-induced obesity environment. 
 Adipose tissue is an important endocrine organ responsible for secreting a 
number of cytokines, including adiponectin and leptin, which have a functional role in 
modulating metabolism. Secretion of adiponectin from adipose tissue has been found 
to be Ca2+ dependent, but the identity of the responsible Ca2+ channel is unknown. 
This study provides evidence that TRPC1 deficient mice have reduced serum 
adiponectin concentration which is believed to be due to an inability of adipose tissue 
to properly secrete adiponectin. Further, it was shown that loss of TRPC1-mediated 
Ca2+ influx is involved in SNARE complex formation necessary for proper exocytosis 
of adiponectin loaded vesicles. 
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 Serum adiponectin concentrations have been shown to be correlated to 
adiponectin receptor expression, thus it was investigated whether reduces in serum 
adiponectin concentrations observed in TRPC1 deficient mice was due to 
dysfunctional adiponectin signaling in muscle. Within this study, it was observed that 
skeletal muscle of TRPC1 deficient mice have reduced adiponectin targets including 
PGC1α, lipid metabolism, and mitochondrial biogenesis mRNA expression. Though 
data suggests AdipoRon initiated adiponectin signaling in muscle is Ca2+ and SOCE 
dependent, TRPC1 is not a contributing member as loss of TRPC1 did not inhibit Ca2+ 
influx or PGC1α expression indicating decreased adiponectin targets is likely due to 
reduce serum adiponectin concentrations. 
 Overall, evidence from the combined studies suggests TRPC1-mediated Ca2+ 
influx is an important regulator of adipocyte processes necessary for maintaining a 
healthy body. 
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CHAPTER I 
INTRODUCTION 
 
Calcium Signaling 
The ability of cells to communicate with their environment and respond 
temporarily to external events is a critical cellular function. This process, called cell 
signaling or signal transduction, is initiated by a receptor-ligand interaction which 
triggers a chain reaction of biochemical and molecular steps which alter cell 
physiology. Calcium (Ca2+) signaling is a particular subtype of cell signaling that 
involves altering the cellular balance of internal versus external cellular Ca2+ 
concentrations. The Ca2+ ion is an important secondary messenger molecule 
involved in regulating numerous cell processes including cell proliferation and 
differentiation, motility, gene transcription, and exocytosis (Berridge et al., 2000). 
At basal conditions, the free intracellular calcium concentration ([Ca2+]i) is 
measured at ~100 nM, while the extracellular concentrations are more than 
20,000-fold greater (Clapham, 2007). Cell stimulation can be in the form of 
electrical, hormonal, or mechanical and can increase the [Ca2+]i to around 1,000 
nM. Increases in [Ca2+]i are the result of either direct Ca2+ entry from the 
extracellular milieu upon membrane depolarization (Woodard and Rosado, 2005) 
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Figure 1 Cellular Ca2+ Regulators 
Schematic diagram of common Ca2+ signaling pathways. Many cells contain 
multiple pathways, but not necessarily all mechanisms shown here are present 
in one single cell type. Influx of Ca2+ is primarily mediated by voltage-operated 
channels (VOCs or VGCCs), receptor-mediated Ca2+ entry (ROC), transient 
receptor potential channels (TRP), ligand-gated channels, and store-operated 
Orai channels (SOC) that are activated by STIM1 protein. Efflux of Ca2+ is 
achieved by PM Ca2+ ATPase (PMCA) or Na+/ Ca2+ exchanger (NCX). Release 
of Ca2+ from the ER is mediated through IP3 (IP3R) receptors. The reuptake of 
Ca2+ into the ER is mediated by ER Ca2+ATPase (SERCA). Other components 
shown include: GPCR (G proteins); PIP2 (phosphatidylinositol 4,5-
bisphosphate); PLC (phospholipase C); PKC (protein kinase C); DAG 
(diacylglycerol); IP3 (inositol 1,4,5-trisphosphate); (IP3R inositol 1,4,5-
trisphosphate receptor). Reprinted from “Functional role of TRP channels in 
modulating ER stress and Autophagy” by P. Sukumaran, 2016, Cell Calcium, 
60, 123-132. Copyright 2016 by Elsevier. Reprinted with permission. 
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or by the process of store-operated Ca2+entry (SOCE), which includes the release 
of Ca2+ stores from the endoplasmic reticulum (ER) that initiates an influx of Ca2+ 
from the extracellular milieu (Parekh and Putney, 2005; Putney, 1986; Putney et 
al., 2017). 
The direct method of Ca2+ entry involves the opening of selective 
Ca2+ channels in the plasma membrane (PM) thus triggering a rapid inflow of 
Ca2+ ions. The most widely understood Ca2+ channels in this process are voltage-
operated channels (VOCs or VGCCs), which are found in excitable cells and are 
activated by changes in electrical membrane potential near the channel (Figure 1). 
VOCs are generally ion-specific and channels have been identified for sodium 
(Na+), potassium (K+), Ca2+, and Chloride (Cl-). The ability of VOCs to promptly 
influx Ca2+ is needed for cellular processes such as muscle contraction or 
exocytosis at synaptic endings (Berridge et al., 2003). Along with VOCs, there are 
many other Ca2+ channels that are initiated by different external signals including 
receptor-operated channels (ROCs), such as the NMDA (N-methyl-D-aspartate) 
receptors (NMDARs) that respond to glutamate. At the end of the signaling event, 
Ca2+ is removed out of the cytoplasm to return the cell to basal [Ca2+]i through PM-
associated pumps and exchangers. The plasma membrane Ca2+ ATPase (PMCA) 
is important for this process and has low capacity but high affinity for Ca2+ transport 
with a stoichiometry of one Ca2+ ion to one ATP (Lopreiato et al., 2014). The 
Na+/Ca2+ (NCX) also performs this job, however, has a low Ca2+ affinity but high 
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capacity for Ca2+ transport giving it the ability to transport Ca2+ quickly out of the 
cell but only at higher concentrations (Brini and Carafoli, 2011). 
Within the cell, Ca2+ is stored inside the ER, mitochondria, lysosomes, Golgi 
and nucleus (La Rovere et al., 2016). The ER is the main Ca2+ storage organelle 
boasting relatively high Ca2+ concentrations that can be quickly released into the 
cytoplasm. SOCE was identified in 1986 and is a ubiquitous PM Ca2+ entry 
mechanism. The process begins with a ligand, such as a hormone, 
neurotransmitter, growth factor, glycoprotein, or cytokine, binds to a G protein-  
coupled receptor (GPCR), thereby activating the receptor (Putney, 1986) (Figure 
1). Ligand docking dissociates GDP from the G protein complex, resulting in the 
detachment of G-alpha subunit and G-beta/G-gamma complex. The GTP bound 
G-alpha subunit then docks to Phospholipase C (PLC) causing a conformational 
change of PLC and hydrolyzing phosphatidylinositol biphosphate (PIP2) into the 
secondary messengers diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) 
(Berridge, 1993). The role of the freed IP3 is to bind with IP3 receptors bound to 
the PM of the ER thus initiating an efflux of ER Ca2+ stores necessary for the 
signaling event (Berridge et al., 2003). When the Ca2+ level in the ER lumen drops 
following IP3 receptor binding, stromal interaction molecule (STIM), a family of 
single-pass ER membrane bound proteins, senses the depleted Ca2+ and 
translocates to the cell’s PM where it activates selective plasma membrane 
Ca2+ channels called SOCs (store-operated Ca2+ channels) to transport 
Ca2+ across the PM from the extracellular milieu (Prakriya and Lewis, 2015). Due 
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to the limited quantity of Ca2+ stored of the ER, ER Ca2+ release can only produce 
transient signals; however, sustained store depletion can induce Ca2+ entry 
through SOCs that is prolonged for minutes to hours. SOCs are not voltage 
dependent, thus they can conduct Ca2+ at negative membrane potentials and are 
complementary to VOCs. The first SOCs were identified in mast cells after whole 
cell patch clamp recordings identified a Ca2+-selective current which was 
characterized by an inward rectification and a reversal potential > +40 mv (Hoth 
and Penner, 1992; Parekh et al., 1997). These channels were termed Ca2+ 
release-activated Ca2+ (CRAC) channels and include ORAI1, ORAI2, and ORAI3. 
The transient receptor potential canonical family (TRPC) of Ca2+ channels has also 
been identified as SOCs and will be discussed more readily in the following 
sections. The induction of Ca2+ influx by SOCs results in an increase in [Ca2+]i 
which is used for the signaling event and to refill the ER via the Ca2+-ATPase 
pump, sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) and the golgi via the 
secretory pathway Ca2+ ATPase (SPCA) (Guerini et al., 2005; Strehler and 
Treiman, 2004). Termination of SOCE occurs following the refilling of the ER by 
SERCA and SOCs return to their original positions (Cao et al., 2015; Jousset et 
al., 2007; Manjarrés et al., 2011).To respond dynamically to the fluctuations of Ca2+ 
signaling needs, cells must be able to accurately control the amount and location 
of Ca2+ influxed through Ca2+ transporters and channels. In the next section, we 
will discuss a particular group of Ca2+ channels important for this process.  
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TRP Family of Ion Channels 
The transient receptor potential channel genes were first discovered in the 
fruit fly Drosophila melanogaster during research centered on understanding the 
Drosophila melanogaster phototransduction cascade in the retina (Cosens and 
Manning, 1969). It was found that light-induced conformational changes of the 
protein rhodopsin stimulated the attached GTP-binding protein thereby activating 
phospholipase-C and an influx of cations. Within this study, a spontaneously 
formed mutant with a blind phenotype was analyzed and the correlating gene 
mutation caused a transient cation influx response to light instead of the expected 
sustained response. Due to these results, the mutated gene and the corresponding 
protein were given the name trp for Transient Receptor Potential (Cosens and 
Manning, 1969). Further research identified that the decline of photoreceptor 
potential in the trp mutant was due to exhaustion of Ca2+ mobility of TRP and 
resulted in a tenfold decrease in Ca2+ influx (Vaca et al., 1994; Xu et al., 1997). 
Since the structure of the mutated trp protein resulting in changes in Ca2+ 
permeability was similar to other known cation channels, it was hypothesized to be 
a new Ca2+ channel involved in the inositol phosphate signaling system (Hardie 
and Minke, 1992; Montell, 1999; Montell and Rubin, 1989). Subsequent 
investigation revealed numerous TRP channels which were grouped into a family. 
TRP channels are tetrameric complexes consisting of four pore-forming 
units (Figure 2). Each unit contains six hydrophobic stretches and a pore loop motif 
intercalated between the fifth and sixth transmembrane segments (Dietrich et al., 
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2014; Nilius, 2007; Pani et al., 2008; Venkatachalam and Montell, 2007). The 1275 
amino acid protein has 3 domains with a neutral 333 amino acid N-terminal 
domain, followed by a 228-amino acid domain with 6 transmembrane segments 
and a hydrophilic 614 amino acid C-terminal domain. The Transient Receptor 
Potential superfamily is broken into seven subfamilies which are separated into 
two groups based on sequence and topological differences. Group 1 consists of 
five subfamilies and includes TRPC (Canonical) (TRPC1–TRPC7), TRPCV 
(Vanilloid) (TRPV1–TRPV6), TRPM (Melastatin) (TRPM1–TRPM8), and TRPA 
(Ankyrin) and TRPN (NOMPC-like). Group 2 includes TRPP (polycystin) (TRPP1-
TRPP2) and TRPML (mucolipin) (TRPML1-TRPML3). Of all the mammalian TRP 
channels, the members of the TRPC sub family are the most closely related to the 
Drosophila TRP (Birnbaumer, 2009; Montell, 2005; Putney, 1986, 1990). 
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Figure 2 TRP Channels 
Phylogenetic tree and topology of TRP channels grouped by structural 
similarities. Subfamilies include TRPC (Canonical) (TRPC1– TRPC7), TRPCV 
(Vanilloid) (TRPV1–TRPV6), TRPM (Melastatin) (TRPM1–TRPM8), and TRPA 
(Ankyrin) and TRPN (NOMPC-like), TRPP (polycystin) (TRPP1-TRPP2) and 
TRPML. Reprinted from “TRP Channels in Disease” by B. Nilius, 2005, Science 
Signaling, 2005, 295. Copyright 2005 by The American Association for the 
Advancement of Science. Reprinted with permission. 
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TRPC Subfamily 
Expression of TRPC channels is ubiquitous in nature and have been found 
in a wide variety of tissues including the brain, hypothalamus, adipose tissue, 
smooth and cardiac muscles, endothelium, kidney, adrenal gland, lung, and 
pituitary glands (Pedersen et al., 2005; Qiu et al., 2010; Sukumar et al., 2012; 
Zanou et al., 2010). The first mammalian TRPC channel to be identified and cloned 
was TRPC1 which lead to the identification of the other members (Wes et al., 
1995). The human TRPC subfamily contains seven members which are separated 
into two individual groups (Figure 3) based on their biochemical and functional 
similarities: TRPC1/4/5 and TRPC3/6/7 (Ong and Ambudkar, 2017). TRPC 
channels are non-selectively permeable to Ca2+, but the selectivity ratio of 
PCa/PNa varies significantly between groups (Ong and Ambudkar, 2017; 
Venkatachalam and Montell, 2007). Sequence homology in TRPC channels is 
found within the block of roughly 25 residues on the C-terminal tail termed the TRP 
domains which includes TRP boxes 1 and 2. TRP box 1 is a conserved amino acid 
sequence of EWKFAR and TRP box 2 is a six-amino acid proline-rich domain. The 
C-terminal tail also includes binding domains for PIP2 and calmodulin (CaM) 
named CIRB. The N-terminal tail of TRPCs contains 3-4 ankyrin repeats and a 
coiled-coil domain of alpha-helices (Ong and Ambudkar, 2011). The domains for 
Homer1, IP3R and caveolin-1 (Cav-1) binding have also been uncovered, but the 
exact function of each of these remains elusive.  
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All TRPC channels are activated by PIP2 hydrolysis and ER Ca2+, though 
not all are involved in SOCE mechanisms (Ong and Ambudkar, 2015). Importantly, 
none of the TRPCs exhibit currents similar to CRAC channels. TRPC channels 
display currents with a relatively linear current-voltage relationship with a reversal 
potential from zero to slightly positive, however this can vary based on cell type 
and complex formation (Cheng et al., 2013). Figure 3 shows representative 
current-voltage relationships for groups of TRPCs. The TRPC channels 3/6/7 are 
unique to the TRPC family as they may be directly activated by DAG or its 
metabolite polyunsaturated fatty acid (PUFAs) (Poburko et al., 2007; 
Venkatachalam and Montell, 2007). One study showed exposure of 
overexpressed TRPC3 channels to exogenous DAG/PUFAs resulted in Ca2+ 
transients indicating TRPC3 channel activation, however, in the presence of DAG 
activated protein kinase C (PKC), TRPC3 channels were inhibited (Soboloff et al., 
2007). In this instance, it was surmised that PKC activation by DAG may be a 
feedback control for TRPC channels. 
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Figure 3 TRPC Channels 
(A) Common topography of TRPC channels along with specific current-
voltage relationships shown below for each TRPC channel grouping. (B) 
Phenotype of TRPC channel genetic deletions. The TRPC7 -/- phenotype has 
not been reported and TRPC2 is a pseudogene in humans. Reprinted from 
“International Union of Basic and Clinical Pharmacology. LXXVI. Current 
progress in the mammalian TRP ion channel family” by L-J. Wu, 2010, 
Pharmacological Reviews, 2010;62(3):381:404. Copyright 2010 by American 
Society for Pharmacology and Experimental Therapeutics. Reprinted with 
permission. 
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TRPC1 Involvement in SOCE 
Data suggests that TRPCs contribute to SOCE mechanisms, although 
certain TRPCs have varying findings. The most consistent and soundest studies 
support a role for TRPC1 in SOCE, however activation of TRPC5, TRPC6, and 
TRPC7 seem to be also activated via store-independent mechanisms (Cheng et 
al., 2013). TRPC3 and TRPC4 have also been implicated in SOCE, although to a 
lesser degree.  
The first evidence of involvement of endogenous TRPC1 in SOCE and 
confirmation of its contribution to Ca2+ permeability was found in human 
submandibular gland (HSG) ductal cells showing that knockdown of TRPC1 
decreased SOCE functionality (Liu et al., 2003). The relative Ca2+-selective 
currents were not consistent to those of CRAC channels, hence, the TRPC1-
mediated currents were termed store-operated calcium current channels (ISOC) as 
they have a reversal potential that is outward rectifying at roughly +15 mV. It had 
been previously established that STIM1 and ORAI1 were necessary components 
of SOCE in that knockdown of either protein abolished SOCE currents (Cheng et 
al., 2008; Jardin et al., 2008; Kim et al., 2009). It was further found that elimination 
of either ORAI1 or STIM1 completely abolished TRPC1-mediated SOCE. The 
current understanding of SOCE mechanisms, shown in Figure 1, is that after ER 
Ca2+ store release, STIM1 interacts with both ORAI1 and TRPC1, however a 
preceding ORAI1-mediated Ca2+ influx is required for TRPC1 function (Ambudkar 
et al., 2017).  
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Within this study, we utilize the 
TRPC1-/- mouse which is missing a coding 
region of exon 8 (Liu et al., 2007). This 
deletion results in a loss of portions of 
transmembrane segments 4 and 5 along 
with a small part of the putative pore 
domain causing the protein to be 
expressed but nonfunctional. Confirmation 
of its competence has been well reported, 
however we confirmed the absence of 
TRPC1 in subcutaneous adipose tissue by assessing TRPC1 mRNA (Figure 4). 
 
Metabolism Regulation 
It is well understood that managing energy within the body to create a 
relatively stable internal environment, or metabolic energy homeostasis, is 
imperative for survival. Metabolic energy homeostasis is maintained by numerous 
mechanisms which monitors systemic nutritional status and responds 
appropriately, both behaviorally and metabolically, to changes in energy 
availability (Yamada et al., 2008). The amount of energy available is in limited 
supply requiring tight regulation so that each organ/tissue and consequently its 
cells function properly. Communication between organs in the form of neuronal 
and hormone signals is imperative, and dysfunction can lead to an imbalance of 
Figure 4 Confirmation of TRPC1 
loss in subcutaneous adipose 
tissue  
RT-PCR expression of TRPC1 from 
subcutaneous adipose tissue of WT 
and TRPC1-/- mice 
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metabolic homeostasis resulting in metabolic disorders. As shown in Figure 5, 
adipose tissue is a major organ responsible for regulating metabolism. Dysfunction 
in adipose tissue is thought to contribute toward a proinflammatory, atherogenic, 
and diabetogenic state along with being linked to the development of chronic 
inflammation, insulin resistance, metabolic syndrome and other obesity related 
disorders (Klöting and Blüher, 2014). An understanding of how adipose tissue 
modulates normal cellular processes is the first step in understanding disease 
related dysfunction. In the following chapters, I will discuss how the involvement of 
TRPC1 in adipose tissue is imperative to maintaining proper function needed for 
metabolic energy homeostasis. 
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Figure 5 Inter-tissue Communication 
Humoral and neuronal pathways allow communication between major organs 
to regulate metabolic information. Neuronal networks controlled by the brain 
function as a negative-feedback mechanism to maintain body weight 
homeostasis, while the liver and other organs possibly representing a 
positive-feedback mechanism. Reprinted from “Inter-organ metabolic 
communication involved in energy homeostasis: Potential therapeutic targets 
for obesity and metabolic syndrome” by T. Yamada, 2008, Pharmacology and 
Therapeutics, 117(1),11. Copyright 2008 by Elsevier. Reprinted with 
permission. 
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CHAPTER II 
METHODS 
Animals   
Chapter III &V 
Male B6129SF2/J (WT) or TRPC1 knockout (TRPC1-/-) mice (Jackson 
Laboratories, Bar Harbor, MI) were used for these experiments. All animals 
were housed in a temperature controlled room under a 12/12 h light/dark 
cycle with ad libitum access to food and water. All animal experiments were 
carried out as per the institutional guidelines for the use and care of animals. 
For high-fat diet and exercise experimentation, four month old males were 
fed diets containing either 16% (normal-fat, NF) or 45% fat (high-fat, HF) for 
12 weeks and subjected to voluntary wheel running exercise. All animal 
protocols were approved by the institutional IACUC committee. 
 
Chapter IV  
Four-month-old male B6129SF2/J (WT) or TRPC1 knockout (KO) mice 
(Jackson Laboratories, Bar Harbor, MI) were fed diets containing either 16% 
(normal-fat, NF) or 45% fat (high-fat, HF) for 12 weeks and subjected to 
voluntary wheel running exercise (exercise, E) or sedentary cage activity 
(sedentary, S). Experimental groups were labeled according to diet and
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 exercise conditions yielding eight groups: WT-NF-E, WT-NF-S, WT-HF-E, 
WT-HF-S, KO-NF-E, KO-NF-S, KO-HF-E, and KO-HF-S. Food intake, body 
weight, and body composition were measured biweekly on alternating 
weeks during the experimental feeding period. After 12 weeks, mice were 
injected with xylazine (Akorn Inc., Decatur, IL) and ketamine (Zoetis Inc., 
Kalamazoo, MI) and then killed by exsanguination according to the animal 
use and care protocol approved by the USDA Agricultural Research Service 
Animal Care and Use Committee. 
 
Stromal vascular fraction (SVF) and primary adipocyte isolation 
Subcutaneous and visceral adipose tissue were weighed and digested with 
0.5% collagenase type I (Gibco Thermo Fisher Scientific, Waltham, MA) at 
37°C for 1 h, adipose tissue cells were filtered using 100 μm nylon cell 
strainers (Corning Life Sciences, Tewksbury, MA) followed by centrifugation 
(1000 rpm, 10 min, 4°C) to separate floating primary adipocytes 
(supernatant) from adipose SVF (cell pellet). The SVF cell pellet was treated 
with RBC lysis buffer (Sigma Aldrich, St. Louis, MO) then quenched with 
DMEM (Dulbecco's modified Eagle's medium; high glucose, L-glutamine) 
and centrifuged (1000 rpm, 10 min, 4°C). Final pellet was resuspended with 
DMEM + 10% FBS. SVF was plated at 70-80% confluence and grown in 
DMEM + 10% FBS + Penicillin Streptomycin. 
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Adipose cell size and number determination 
The supernatant from digested adipose tissue (see above) was washed and 
resuspended in 0.9% NaCl. Adipose cell size and number determination 
was determined using a Beckman Coulter Multisizer 4 with a 400-μm 
aperture. The instrument was set to count 6000 particles and the cell 
suspension was diluted so that coincident counting was <10%. After 
collection of pulse sizes, the data were expressed as cell numbers per 
particle diameter. 
 
SVF differentiation 
SVF was grown to a minimum of 80% confluence and differentiated for 36 
hours in a cocktail of DMEM (10% FBS + Pen/Strep), 25mM glucose, 2 uM 
dexamethasone (Sigma Aldrich, St. Louis, MO), 300 nM insulin (Sigma 
Aldrich, St. Louis, MO), and 20 uM PGJ2 (Caymen Chemical, Ann Arbor, 
MI). After 36 hours of differentiation, media was removed and cells were 
grown in DMEM (10% FBS + Pen/Strep) for 7-10 days. 
 
Chapter III 
For differentiation experiments utilizing SKF and increased Ca2+ 
concentrations, cells were differentiated with the addition of SKF96365 
(Sigma Aldrich, St. Louis, MO) or CaCl2. Final concentrations of Ca2+ were 
1x-1.8 mM, 2x-3.6mM, 4x-5.4mM. 
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C2C12 cell culture and differentiation 
The mouse skeletal cell line C2C12 was cultured in DMEM (Dulbecco's 
modified Eagle's medium; high glucose, L-glutamine) + 20% FBS + 1% 
Pen/Strep and incubated at 37 °C, 5% CO2. At 80% confluence media was 
switched to DMEM + 2% horse serum + 1uM Insulin for 3 days and then 
DMEM + 2% horse serum for the remaining 4-7 days until fully 
differentiated. 
 
EchoMRI measurements of body composition 
Whole body composition, including fat mass and lean mass, was 
determined biweekly during the 12 week period without sedation using 
nuclear magnetic resonance technology with the EchoMRI700™ instrument 
(Echo Medical Systems, Houston, TX). 
 
Red Oil Staining 
Culture plates were washed by PBS and cells were fixed in 4% formalin, 
followed by staining with oil-red-O (Sigma Aldrich, St. Louis, MO) for 10 min, 
washed, and photographed. The dye was then extracted with 100% 
isopropanol and the absorbance was determined at 492 nm. 
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Gas chromatography/mass spectrometry (GC/MS) 
Tissue samples were pulverized under liquid nitrogen conditions to a fine 
homogeneous powder.  Lipids were extracted with hexane/2-propanol 
(3:2, v/v, HIP) as previously described (Saunders and Horrocks, 1984).  
Briefly, ~10 mg of tissue powder was homogenized in 2 ml of HIP using a 
2 mL Tenbroeck tissue grinder (Kontes Glass Co.).  HIP contained 
0.005% of butylated hydroxytoluene (BHT) to prevent fatty acid oxidation, 
and a mixture of stable isotope labeled internal standards (Cambridge 
Isotope Laboratories, Tewksbury, MA) for quantification.  For each 
sample, we used 100 ng of 10:0-2H17 for short chain FA quantification, 5 
µg of 16:0-13C16 for saturated long chain FA, 1 µg of 18:1-13C18 for 
monounsaturated FA, and 1 µg of 20:4n6-2H8 for polyunsaturated FA.  
After centrifugation, HIP supernatant was evaporated under a stream of 
nitrogen and subjected to saponification to release FA as previously 
described (Brose et al., 2014).  Briefly, lipids were re-dissolved in 260 µL 
of methanol containing 0.02% BHT (0.158mg/mL) add 40 µL 5M KOH (in 
water), and saponified at 60°C for 60 min in a water bath.  The solution 
was neutralized with the addition of 20 µL 5 M HCl followed by the addition 
of 780 µL 0.9% NaCl.  The free FA were extracted with 2 mL hexane 3 
times. The hexane extracts were combined, dried under nitrogen stream, 
re-dissolved in 1 mL of hexane, 100 µL (for short chain FA) or 1 µL (for 
long chain FA) was transferred into micro-inserts (National Scientific, 
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Rockwoods, TN; catalog No. C4010-S630), evaporated under nitrogen 
stream, and finally re-dissolved in 100 µL of the initial UPLC gradient for 
analysis.   
UPLC-MS analysis was performed as previously described (Brose et al., 
2014; Wang et al., 2014).  The UPLC system consisted of a Waters 
ACQUITY UPLC pump with a well-plate autosampler (Waters, Milford, 
MA) equipped with an ACUITY UPLC HSS T3 column (1.8 µM, 100 A pore 
diameter, 2.1×150 mm, Waters) and an ACUITY UPLC HSS T3 Vanguard 
precolumn (1.8 µM, 100 A pore diameter 2.1 × 5 mm, Waters). One 
microliter of a sample was injected onto the column. The column 
temperature was 55°C and the autosampler temperature was 8°C. 
Solvent A consisted of acetonitrile : water (40 : 60) with 10 µM ammonium 
acetate and 0.025% acetic acid.  Solvent B was acetonitrile : 2-propanol 
(10 : 90) containing 10 µM ammonium acetate and 0.02% acetic acid. The 
flow rate was 0.3 mL/min, and the initial %B was 30%.  At 0.1 min %B was 
increased to 54% over 10 min, to 99% over another 10 min, held at 99% 
for 8 min, and then returned to initial conditions over 0.5 min. The column 
was equilibrated for 2.5 min between injections. 
FA were quantified using a quadrupole time-of-flight mass spectrometer 
(Q-TOF, Synapt G2-S, Waters) with electrospray ionization in negative ion 
mode as described previously (Brose et al., 2014; Wang et al., 2014). The 
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analyzer was operated with extended dynamic range at 10,000 resolution 
(fwhm at m/z 554) with an acquisition time of 0.1s. MSE mode was used to 
collect data.  Leucine enkephalin (400 pg/µl, ACN : water, 50 : 50 by 
volume) was infused at a rate of 10 µl/min for mass correction. MassLynx 
V4.1 software (Waters) was used for instrument control, acquisition, and 
sample analysis.  FA were quantified against corresponding internal 
standards using generated standard curves.  
Blood collection and serum isolation 
Mice were anaesthetized with an injected of xylazine (Akorn Inc., Decatur, 
IL) and ketamine (Zoetis Inc., Kalamazoo, MI). A 3 cc syringe with a 22-25 
gauge x 1" needle was inserted from the posterior aspect and animal was 
terminally bled. Whole blood was allowed to coagulant for 30 min at room 
temperature. Blood was then centrifuged at 2,000 x g for 15 minutes at 4°C 
and serum was removed from clotted blood and frozen at -20°C. 
 
Adiponectin and Leptin Concentrations 
Serum, culture media, and protein lysates samples were analyzed for 
adiponectin and leptin using the adiponectin mouse ELISA kit (Abcam, 
Cambridge, UK) and Leptin Mouse ELISA kit (Invitrogen, Carlsbad, CA). 
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Glucose tolerance test 
At the end of 12 weeks of feeding, mice were fasted overnight and then 
injected with 2 g/kg body weight of 20% D-glucose (Sigma Aldrich, St. Louis, 
MO) intraperitoneally. Approximately 5 μl of tail blood, obtained through tail 
nick procedure, was used to measure the blood glucose concentrations 
using the Accu Check Aviva glucometer at baseline and then 15, 30, 60 and 
120 min post glucose injection. 
 
Measurement of plasma insulin 
Mice were fasted overnight and then plasma was obtained to analyze insulin 
concentrations (Insulin ELISA kit: EXRMI-13K, EMD Millipore, St. Charles, 
MO) using the Bio-Rad Luminex system (Hercules, CA) according to 
manufacturer’s protocols. 
 
Electrophysiology  
For patch clamp experiments, coverslips with cells were transferred to the 
recording chamber and perfused with an external Ringer's solution of the 
following composition (mM): NaCl, 145; CsCl, 5; MgCl2, 1; CaCl2, 1; Hepes, 
10; Glucose, 10; pH 7.3 (NaOH). Whole cell currents were recorded using 
an Axopatch 200B (Axon Instruments, Sunnyvale, CA, USA). The patch 
pipette had resistances between 3 -5 MΩ after filling with the standard 
intracellular solution that contained the following (mM): cesium methane 
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sulfonate, 150; NaCl, 8; Hepes, 10; EGTA, 10; pH 7.2 (CsOH). Basal leak 
was subtracted from the final currents and average currents are shown. The 
maximum peak currents were calculated at a holding potential of –80 mV. 
The voltage-current (I-V) curves were made using a ramp protocol ranging 
from -100mV to +100mV and 100ms duration were delivered at 2s intervals, 
whereby current density was evaluated at various membrane potentials and 
plotted.  
 
Calcium imaging 
Cells were incubated with 2uM Fura-2 (Molecular Probes, Eugene, OR, 
USA) and the fluorescence intensity was monitored with a CCD camera-
based imaging system (Compix, Cranbery, PA, USA) mounted on an 
Olympus (Shinjuku, Tokyo, Japan) XL70 inverted microscope equipped 
with an Olympus 40× (1.3 NA) objective. A dual wavelength monochromator 
enabled alternative excitation at 340 and 380 nm, whereas the emission 
fluorescence was monitored at 510 nm with an Orca Imaging camera 
(Hamamatsu, Shizuoka Prefecture, Japan). Fluorescence traces shown 
represent [Ca2+]i values in 340/380 nm ratio that are a representation of 
results obtained in at least 3-4 individual experiments using 40-70 cells in 
each experiment. 
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PCR analysis  
Adipose tissue 
Total RNA was extracted using the RNeasy Lipid Tissue Mini kit and 
Qiacube (Qiagen, Valencia, CA) from flash-frozen subcutaneous adipose 
tissue. cDNA was synthesized using the Quantitect Reverse Transcriptase 
kit (Qiagen, Valencia, CA) Rox FastStart Universal Probe Master mix assay 
reagents were purchased from Roche (Indianapolis, IN). Primers were 
purchased from Integrated DNA Technology (IDT, Coralville, IA). The 
endogenous control (18S rRNA) was purchased from Applied Biosystems 
(Foster City, CA). RT-PCR analysis for TRPC1 transcripts was done with 
primers from the eighth and ninth exons (Up-5’ 
GCAACCTTTGCCCTCAAAGTG and Dn-5’ GGAGGAACATT-
CCCAGAAATTTCC) after the EcoRI site (Eurofins MWG Operon, 
Huntsville, AL). 
 
qPCR analysis 
Chapter IV 
Total RNA was extracted using the RNeasy Lipid Tissue Mini kit and 
Qiacube (Qiagen, Valencia, CA) from flash-frozen hind leg biceps femoris 
skeletal muscle or subcutaneous adipose tissue. cDNA was synthesized 
using the Quantitect Reverse Transcriptase kit (Qiagen, Valencia, CA) and 
then used to measure expression of glucose transporter type 4 (GLUT4), 
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hypoxia-inducible factor 1-alpha (HIF1α), fibroblast growth factor 21 
(FGF21), peroxisome proliferator-activated receptor gamma (PPARγ), 
microtubule-associated proteins 1A/1B light chain 3A (MAP1LC3A), and 
beclin 1 (BECN1) by qPCR (ABI Prism 7500 PCR System, Applied 
Biosystems, Foster City, CA). Rox FastStart Universal Probe Master mix 
assay eagents were purchased from Roche (Indianapolis, IN). Primers were 
purchased from Integrated DNA Technology (IDT, Coralville, IA). The 
control (18S rRNA) was purchased from Applied Biosystems (Foster City, 
CA). 
 
Chapter VI 
Total RNA was extracted from liver and bicep femoris (BF) skeletal muscle 
using Quick-RNA Miniprep kit (Zymo Research, Irvine, CA). cDNA was 
synthesized using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) 
and expression was measured using SsoAdvanced Universal SYBR Green 
Supermix (Bio-Rad, Hercules, CA). Primers were purchased from Thermo 
Fisher (Waltham, MA) with the sequences in Table 1. Analysis of expression 
was calculated by using the endogenous control (18S rRNA) and the ΔΔCT 
method. 
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Table 1 Primer Sequences 
Symbol Gene 
Accession 
number Primer Sequence 
ERRα Estrogen-Related Receptor Alpha NM_007953.2 
fwd-GGAAGTGCTGGTGCTGGGTGT 
rev-GAATTGGCAAGGGCCAGAGCT 
NRF1 Nuclear Respiratory Factor 1 NM_001293164.1 
fwd-GGAGCACTTACTGGAGTCC  
rev-CTGTCCGATATCCTGGTGGT 
TFAM Transcription Factor A NM_001361693.1 
fwd-CCTGAGGAAAAGCAGGCATA  
rev-ATGTCTCCGGATCGTTTCAC 
ACC Acetyl-Coenzyme A Carboxylase NM_133360.2 
fwd-GTCCCCAGGGATGAACCAATA 
rev-GCCATGCTCAACCAAAGTAGC 
FASN Fatty Acid Syntase NM_007988.3 
fwd-AGAGATCCCGAGACGCTTCT 
rev-GCCTGGTAGGCATTCTGTAGT 
ACADM 
Acyl-Coenzyme A 
Dehydrogenase, Medium 
Chain 
NM_007382.5 
fwd-AGAGCTCTAGACGAAGCCACGA 
rev-GAGTTCAACCTTCATCGCCATT 
PGC1a PPARG Coactivator 1 Alpha 
  
NM_008904.2 
fwd-AAACTTGCTAGCGGTCCTCA 
rev-TGGCTGGTGCCAGTAAGAG 
18s     
fwd-GCCGCTAGAGGTGAAATTCTTG 
    rev-CTTTCGCTCTGGTCCGTCTT 
 
Muscle Isolation and Culture 
Extensor Digitorum Longus (EDL) muscle was isolated from WT and 
TRPC1-/- mice and digested using a solution of 0.2% Collagenase type I 
(Gibco Thermo Fisher Scientific, Waltham, MA) in DMEM (Dulbecco's 
modified Eagle's medium; high glucose, L-glutamine with 110 mg/ml sodium 
pyruvate) for 1 hour at 37°C. Tissue was transferred to a horse serum lined 
dish with DMEM and flushed until individual fibers were released from 
tissue. Each fiber was moved to a separate dish coated with Matrigel 
(Corning, Corning, NY) and suspended in DMEM with 20% FBS, 1% 
Chicken Embryo extract (Accurate Chemical, Westbury, NY) and 1% 
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Penicillin/Streptomycin. Myofibers were incubated for 4 days at 37 °C, 5% 
CO2 without handling to allow myofibers to adhere and activate satellite 
cells. Following that time frame, media was replaced every other day until 
cells naturally differentiated ~ 14 days. Confirmation of differentiation was 
obtained by visually observing new muscle formation and contraction. 
 
Immunoblotting 
Crude lysates were prepared from Subc AT and VAT and SVF and 
differentiated adipocyte cultures. 40 μg of proteins were resolved on 
NuPAGE Novex 4-12% Bis-Tris gels, transferred to nitrocellulose 
membranes, and probed with respective antibodies (all from Cell Signaling). 
Respective peroxidase conjugated secondary antibodies were used to label 
the proteins, which were then detected by an enhanced chemiluminescence 
detection kit (SuperSignal West Pico, Pierce, Appleton, WI). Densitometric 
analysis was performed using image J analysis (National Institutes of 
Health) and results were corrected for protein loading by normalization to 
β-actin levels. Non-denaturing PAGE was performed by resolving protein in 
Novex Tris-Glycine Native Sample Buffer on NuPAGE™ 3-8% Tris-Acetate 
Protein Gels, transferred to nitrocellulose membranes, and probed with 
respective antibodies. Membranes were stained with Ponceau S (Sigma 
Aldrich, St. Louis, MO) and bands were quantified using image J analysis 
to determine total protein load.  
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Co-immunoblotting 
Subc AT and VAT was manually homogenized in the presence of HBSS 
containing Ca2+ and Mg2+ and then treated as described for 30 min at 37°C. 
Samples were incubated overnight with anti-VAMP2 antibody after which 
agarose anti-mouse IgG beads were added. Isolated beads were then 
washed, boiled, and separated by SDS-PAGE. SNARE proteins were 
detected using the indicated antibodies.  
 
Adiponectin Secretion from Fresh Adipose Tissue 
Isolated subcutaneous and visceral adipose tissue was suspended in 
Hank’s balanced salt solution (HBSS) (Gibco) supplemented with 1.26 mM 
CaCl2, 0.5 mM MgCl2, and 2% bovine serum albumin (Fisher Scientific, 
Hampton, NH). Adipose tissue was cut into 8-15 mg pieces and suspended 
in supplemented HBSS for 30 min at 37°C to recover. Samples were then 
placed into a 96 well plate suspended in DMEM containing 2% BSA, 
stimulated with 100 nM insulin (Sigma Aldrich, St. Louis, MO) for 6 hours. 
 
Statistical Analysis 
Mean and standard error values were computed for all continuous variables 
and frequency distributions were calculated for all categorical variables 
using GraphPad Prism 7. Statistical comparisons were made using two-
tailed Student’s t test or ANOVA and the effects of TRPC1 KO, diet, or 
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exercise were assessed by three-way ANOVA.  When an interaction was 
significant (p < 0.05), Tukey contrasts were used to perform pairwise 
comparisons. All statistical tests were two-tailed with significant reported as 
follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. 
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CHAPTER III 
LOSS OF TRPC1 IN ADIPOCYTES IMPAIRS DIFFERENTIATION 
 
Introduction 
Intracellular Ca2+ signaling has been suggested to play several important 
roles in regulating cellular energy metabolism (Filadi et al., 2017); however, the 
specific Ca2+ ion channels involved have not yet been identified. As we’ve stated 
before, TRPC1 functions as a Ca2+ entry channel that is found in key metabolic 
tissues, including the hypothalamus (Qiu et al., 2010), adipose tissue (Sukumar et 
al., 2012), and skeletal muscle (Zanou et al., 2010), making it a likely candidate for 
the regulation of cellular energy metabolism. As such, functional disturbance of 
TRP family channels could play a role in regulating adiposity and obesity-related 
conditions such as insulin resistance (Graham et al., 2009; Hu et al., 2009; 
Sabourin et al., 2015).  
Adipocytes are vital to maintaining lipid homeostasis and energy balance 
by storing triglycerides and releasing free fatty acids in response to energy need 
changes (Rosen and Spiegelman, 2006). Though adipose tissue is an important 
endocrine organ, excessive accumulation of adipose tissue, defined as obesity, is 
a major risk factor for insulin resistance and other diseases such as Type II 
diabetes, dyslipidemia, and cardiovascular disorders (Wu et al., 1999). Adipocytes
32 
 
are the predominant cell type in adipose tissue; however, not all adipose tissue 
functions identically. Several studies have shown that anatomical distribution of 
adipose tissue dictates differing characteristics where subcutaneous adipocytes 
have distinct metabolic properties from visceral adipocytes (Baglioni et al., 2012). 
Proliferation of the subcutaneous adipose tissue (Subc AT) may be considered 
beneficial, in part, by increasing “healthy” lipid storage capacity that produces 
fewer inflammatory cytokines. Whereas, visceral adipose tissue (VAT) is thought 
to be more inflammatory (Kadiri et al., 2017; O'Rourke et al., 2009) and leads to 
the development of obesity and related metabolic diseases (Foster et al., 2011; 
Seale et al., 2011). Although the debate about the metabolic function of Subc AT 
and VAT is not yet settled (Fabbrini et al., 2010; Thörne et al., 2002), variances in 
distribution of lipids in Subc AT and VAT could be critical in the development of 
metabolic diseases.  
One such area to investigate regarding variances between Subc AT and 
VAT tissues could be the process of differentiation of committed preadipocytes into 
mature adipocytes. Interestingly, it has been shown that differentiation is impaired 
in Subc preadipocytes of obese subjects and their ability to differentiate is 
negatively correlated to BMI and cell size (Isakson et al., 2009). Further, in an 
obese state, the preadipocyte to mature adipocyte ratio is reduced and the ability 
of Subc AT to differentiate properly may be diminished pushing the accumulation 
of fat to visceral depots (Tchoukalova et al., 2007). Similar results have shown an 
age-dependent decline in differentiation and increases in adipose tissue 
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accumulation in obesity is likely due to hypertrophy instead of hyperplasia (Kim et 
al., 2014).  
 Although several nuclear receptors and transcription factors that regulate 
adipocyte differentiation and adipogenesis have been identified (Farmer, 2006), 
Figure 6 Schematic of adipocyte differentiation 
The induction of transcription factors C/EBPβ and C/EBPδ are induced early 
during adipogenesis with PPARγ induction occurring shortly after. Lipid droplet 
formation and expression of mature adipocyte proteins such as FAPB4, perilipin, 
and adiponectin occur during the late stage. Reprinted from “Cellular models for 
the evaluation of the antiobesity effect of selected phytochemicals from food and 
herbs” by Y-C. Tung, 2017, Journal of Food and Drug Analysis, 25(1), 100-110. 
Copyright 2017 by Elsevier. Reprinted with permission. 
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factors upstream to the activation of these transcription factors are still unknown. 
Adipogenesis is an intricate process involving coordinated temporal and spatial 
control of a transcriptional system which regulates the expression of adipocyte-
specific genes (Figure 6). The first step involves the initiation of the 
CCAAT/enhancer-binding proteins (C/EBPs) family of transcription factors 
including C/EBPβ and C/EBPδ with C/EBPα and Peroxisome proliferator–
activated receptor γ (PPARγ) activation occurring in the intermediate or late stage 
of adipogenesis (Garin-Shkolnik et al., 2014). Although the C/EBP transcription 
factors seem to work in conjunction with PPARγ, PPARγ has been determined to 
have a dominant role and functions as a master regulator of adipogenesis (Haider 
et al., 2017). PPARγ has been linked to the transcription of genes expressed in 
mature adipocytes such as fatty acid binding protein (FABP4), required for 
transport of free fatty acids, and perilipin (PLIN1), which covers the surface of 
mature lipid droplets in adipocytes and regulates lipolysis. PPARγ also regulates 
lipoprotein lipase (LPL), adiponectin (ADIPOQ), fatty acid transporter CD36 
(CD36), glycerol-3-phosphate dehydrogenase (GPD1), and insulin-responsive 
glucose transporter 4 (GLUT4), all involved in regulating lipid and glucose 
metabolism (Rosen et al., 1999; Siersbaek et al., 2010; Tung et al., 2017). Not 
surprisingly, several studies have demonstrated that PPARγ has a role in 
metabolic diseases. Mutations to the PPARγ gene have been linked to type II 
diabetes, obesity, hypertension and insulin resistance (Pap et al., 2016), while 
adipose-specific knockout of PPARγ in mice fed a high-fat diet display insulin 
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resistance in adipose tissue and liver, but not in muscle (He et al., 2003). PPARγ 
agonists, such as rosiglitazone and pioglitazone, which are part of the 
thiazolidinediones (TZD) family, have been widely used in the treatment of type II 
diabetes due to their ability to enhance insulin sensitivity and increase adiponectin 
levels (Mooradian et al., 2002; Saltiel and Olefsky, 1996; Yang et al., 2002).  
Calcium has been identified as important for the transcriptional regulation 
of adipocyte differentiation; however, the molecular identity of the Са2+ channel 
has yet to be identified. Studies on preadipocytes show that elevating [Ca2+]i early 
in differentiation inhibits PPARγ induction and triglyceride accumulation (Neal and 
Clipstone, 2002; Shi et al., 2000). Similarly, elevating extracellular Ca2+ 
concentrations, with no change in [Ca2+]i, inhibited adipocyte differentiation in 
white (Jensen et al., 2004) and brown (Pramme-Steinwachs et al., 2017) 
adipocytes.  In contrast, elevations of [Ca2+]i during late adipogenesis promoted 
lipogenesis and GPDH activity in white adipocytes (Shi et al., 2000). Though 
elevating extracellular calcium concentrations had negative effects on white and 
brown adipocyte differentiation, reducing extracellular concentrations had the 
opposite effect on brown adipocytes where decreased levels increased brown 
adipocyte differentiation (Pramme-Steinwachs et al., 2017). Finally, initiating a 
Са2+ response through the usage of angiotensin II is known to modulate adipocyte 
proliferation and differentiation, triglyceride accumulation, expression of adipokine-
encoding genes and adipokine secretion (Shum et al., 2013). Together these 
studies demonstrate the importance of modulating Са2+ during differentiation, 
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however the mechanism and channel necessary is still unknown. Microarray 
analysis has shown both TRPC1 and TRPC5 expression are amplified when 3T3-
L1 adipocytes mature; however, the physiological characterization of the Ca2+ 
entry channel in subcutaneous and visceral adipocytes is still missing (Sukumar et 
al., 2012). Additional data from this study is shown in Figure 7 confirming the 
expression of TRPC1 and TRPC5 in mouse epididymal adipose tissue and 
perivascular adipose from humans with coronary artery disease (CAD). It is 
notable that this study found TRPC1 expression surmounted TRPC5 expression 
at both the RNA and protein level. It was also recently shown in El Hachmane et 
al., 2018 that SOCE proteins STIM1, ORAI1, and TRPC1 are highly expressed in 
3T3-L1 adipocyte cell line and play a functional role in SOCE mechanisms further 
indicating the importance of TRPC1 in adipose function.  
The aim of this study was to identify the endogenous Ca2+ entry channel in 
adipocytes cells and establish its physiological function in modulating adipocyte 
differentiation. We report for the first time the adipose tissue-dependent differences 
in sensitivity to SOCE, differentiation, and lipid accumulation. We further report that 
the endogenous Ca2+ entry channel in adipocytes is dependent on TRPC1 and 
loss of TRPC1 function inhibits adipocyte differentiation. These results suggest 
TRPC1 is crucial for adipocytes differentiation, which plays an important role in 
regulating metabolic homeostasis. 
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A B 
C D 
Figure 7 TRPC1 and TRPC5 expression in mouse and human adipose 
(A) RNA RT-PCR products from mouse epididymal adipose tissue. Analysis of 
mRNA from human coronary artery disease (CAD) perivascular adipose by RT-
PCR (B) and western blot protein (C). (D) Immunostaining (brown colour in the 
upper panels indicates channel detection) of TRPC1 and TRPC5. The control 
was the antibody (Ab) preadsorbed to its antigenic peptide (+pep). Scale bar, 
100 μm. Reprinted from “Constitutively Active TRPC Channels of Adipocytes 
Confer a Mechanism for Sensing Dietary Fatty Acids and Regulating 
Adiponectin”, P. Sukumar, 2012, Circulation Research, 111(2), 191-200. 
Copyright 2012 by Wolters Kluwer Health, Inc. Reprinted with permission. 
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Results 
 
Subcutaneous and visceral adipocytes display SOCE mechanisms 
To establish the molecular identity of the SOCE channel in adipose cells, 
we evaluated Ca2+ signaling in isolated stromal vascular fraction (SVF) of mouse 
adipose tissue. Addition of thapsigargin (1mM, Tg), a SERCA pump blocker that 
causes loss of Ca2+ from the internal ER stores, showed a small increase in 
intracellular Ca2+ ([Ca2+]i ) levels (first peak) in subcutaneous adipose tissue (Subc 
AT) SVF cells (Figure 8 A, B). Addition of 1mM external Ca2+, Subc AT SVF cells 
showed a significant increase in [Ca2+]i  (second peak), indicating the presence of 
store-mediated Ca2+ entry (Figure 8 A, B). Importantly, Subc AT SVF cells treated 
with SKF96365 (10mM SKF, a blocker of store-mediated Ca2+ influx channels) 
were observed to have a significant reduction in SOCE without any change in 
internal ER Ca2+ release (Figure 8 A, B).  
To establish the molecular identity of the Ca2+ influx channel in Subc AT 
SVF cells, electrophysiological recordings of membrane currents were performed. 
Addition of Tg induced an inward current, which was non-selective in nature and 
reversed between 0 and -5 mV (Figure 8 C, D). The current properties observed 
in Subc AT SVF cells were similar with previous recordings observed of TRPC1 
channels (Liu et al., 2004; Selvaraj et al., 2012; Shi et al., 2012; Yuan et al., 2007). 
Moreover, pretreatment with SKF significantly inhibited the Tg-induced  
39 
 
 
Figure 8 Subc AT SVF exhibits SOCE  
Representative Fura-2 traces showing the transient increase in [Ca2+]i after 
addition of 1 μM Tg and 1 mM Ca2+ to Subc AT SVF cells (A) in control and 
cells pretreated with 10 μM SKF for 15 min. Bar diagram quantifies Tg-induced 
ER Ca2+ release and Ca2+ entry peaks for Subc AT SVF cells (B) under these 
conditions. Each bar gives the mean ± SEM of 40–60 cells in three separate 
experiments. Application 1 μM Tg in bath solution induced inward currents at 
−80mV in control and SKF treated Subc AT SVF cells (C). Respectively IV 
curves under these conditions are shown for Subc AT SVF in (D). Quantitation 
(n = 7 recordings) of current intensity at −80 mV is shown for Subc AT SVF in 
(E). Graphs are mean ± SEM, significance: *, p < 0.05. 
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nonselective current (Figure 8 C-E), suggesting that in Subc AT SVF cells, the 
SOCE mechanism is dependent on TRPC1 channels.  
We next evaluated the physiological properties of the SOCE channels in 
differentiated adipocytes from Subc AT. Samples taken from both Subc AT 
deposits were cultured and differentiated into mature adipocytes ex vivo. Similar 
to the observed response in Subc AT SVF cells, differentiated Subc adipocytes 
showed no change in the ER Ca2+ release (upon addition of Tg, 1mM) (Figure 9 
A,B). Addition of 1mM external Ca2+ again resulted in an increase in [Ca2+]i, which 
were significantly reduced when treated with SKF as compared to untreated 
Control (Figure 9 A,B). Furthermore, a similar TRPC1-like current was observed in 
differentiated Subc AT adipocytes during whole cell patch clamp recordings and 
the Tg-induced currents were again inhibited by SKF (Figure 9 C-E).  Comparison 
of Current-Voltage (I-V) Curves of Subc AT SVF and differentiated Subc AT 
adipocytes indicated a ~25% increase in amplitude of TRPC1-like currents in 
differentiated Subc AT (Figure 8 E, Figure 9 E).  
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Figure 9 Blockage of SOCE in differentiated Subc AT by SKF 
Representative Fura-2 traces showing the transient [Ca2+]i after addition of 1 μM 
Tg and 1 mM Ca2+ to differentiated Subc AT (A) in control and cells pretreated 
with 10 μM SKF for 15 min. (B) Bar diagram quantifies Tg-induced ER Ca2+ 
release and Ca2+ entry peaks under these conditions. Each bar gives the mean 
± SEM of 40–60 cells in three separate experiments. Application 1 μM Tg in bath 
solution induced inward currents at −80mV in control and SKF treated 
differentiated Subc AT (C). Respectively IV curves under these conditions are 
shown in (D). Quantitation (n = 7 recordings) of current intensity at −80 mV is 
shown in (E). Graphs are mean ± SEM, significance: *, p < 0.05; ***,  p < 0.001. 
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To confirm that TRPC1 is involved in modulating SOCE, protein expression 
of TRPC1, STIM1, and ORAI1 in both Subc AT SVF and differentiated Subc AT 
was analyzed. Consistent with other studies, expression of TRPC1 and STIM1 was 
increased upon differentiation (Graham et al., 2009; Sukumar et al., 2012); 
however, there was no change in ORAI1 expression (Figure 10 A, C). Known 
markers of adipocyte differentiation, FABP4 and perilipin, were used to confirm 
differentiation.  
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Figure 10 Changes in Ca2+ channel expression during differentiation in 
Subc AT and VAT 
Western blot and quantification of TRPC1, ORAI1, Stim1, FAPB4, and perilipin 
protein expression normalized to actin of Subc AT SVF and differentiated Subc 
AT (A,C) and VAT SVF and differentiated VAT (B,D). Graphs are mean ± SEM, 
significance: *, p < 0.05; **, p < 0.01. 
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Differentiated visceral adipocytes exhibit increased  
store-operated Ca2+ entry 
White AT has different properties based on its location. It is well known that 
visceral adipose tissue (VAT), when compared with Subc AT, is functionally 
different in that VAT has higher inflammatory potential (Zhou et al., 2007) due to 
increased localization of inflammatory and immune cells. VAT has greater 
oxidative capacity and lipolysis potential than Subc AT and less capacity to 
differentiate resulting in a greater percentage of large adipocytes as compared to 
Subc AT (Ibrahim, 2010). To date, it is unknown whether store-mediated changes 
in [Ca2+]i leading to adipocyte differentiation is analogous between VAT and Subc 
AT. Thus, we investigated SOCE from adipocytes derived from the VAT depots. 
Consistent with Subc AT protein expression, STIM1, ORAI1 and TRPC1 were 
expressed in both VAT SVF and differentiated VAT adipocytes with increased 
expression of STIM1 and TRPC1 seen in differentiated VAT, and again no change 
in ORAI1 expression (Figure 10 B, D).  
Measurements of membrane current recordings of VAT SVF adipocytes 
induced upon the addition of Tg (1mM) showed an inward TRPC1-like current and 
pretreatment with SKF (10mM) significantly inhibited the nonselective current 
(Figure 11 A, B). Importantly, after differentiation, the similar TRPC1-like current 
was observed in VAT cells (Figure 11 D, E) and a ~50% increase in the current 
amplitude was observed upon differentiation (Figure 11 C, F). Again Tg-induced 
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currents were inhibited by the addition of SKF in differentiated VAT adipocytes 
(Figure 11 D, E).  
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Figure 11 Increased SOCE currents in differentiated VAT 
Application of 1 μM Tg in bath solution induced inward currents at −80mV in 
control and SKF treated VAT SVF cells (A) and differentiated VAT (D). 
Respectively IV curves under these conditions are shown for VAT SVF in (B) and 
differentiated VAT in (E). Quantitation (n = 5 recordings) of current intensity at 
−80 mV is shown for VAT SVF in (C) and differentiated VAT in (F). Graphs are 
mean ± SEM, significance: *, p < 0.05. 
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Calcium imaging of VAT SVF adipocytes treated with SKF had no change 
in internal Ca2+ release, but had a significant reduction in SOCE upon the addition 
of 1mM external Ca2+ (Figure 12 A, B). However, differentiated VAT adipocytes 
treated with SKF showed a reduction in both internal Ca2+ ER store release upon 
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Figure 12 Fura-2 Traces of SVF and differentiated VAT 
Representative Fura-2 traces showing the transient increase in [Ca2+]i after 
addition of 1 μM Tg and 1 mM Ca2+ to VAT SVF cells (A) and differentiated 
VAT (C) pretreated with 10 μM SKF for 15 min. Bar diagram quantifies Fura-2 
Tg and Ca2+ peaks for VAT SVF cells (B) and differentiated VAT (D). Each bar 
gives the mean ± SEM of 40–60 cells in three separate experiments. Graphs 
are mean ± SEM, significance: *, p < 0.05; **, p < 0.01. 
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Tg treatment and SOCE upon addition of external Ca2+ which could be attributed 
to slightly smaller ER stores in the cells sampled or a specific response of 
differentiated VAT to SKF (Figure 12 C, D). These results indicate that 
differentiated VAT adipocytes may be more sensitive to alterations in store-
operated Ca2+ entry than VAT SVF adipocytes, however the properties of both 
Subc AT and VAT exhibit similar SOCE functionality.  
 
 
Figure 13 Inhibition of SOCE impairs ability of adipocytes to differentiate 
(A) Oil-red-o staining (using 10X objective) of Subc AT and VAT differentiated in 
the presence of SKF (10 µM) for 7 days. Quantification of absorbance at 492nm 
of stained lipid droplets using eluted oil-red-o stain for Subc AT (B) and VAT (D).  
Western blot of PPARg, FAPB4, and perilipin protein expression of Subc AT (C) 
and VAT (E) differentiated in the presence of SKF. Graphs are mean ± SEM, 
significance: ***, p < 0.001; ****, p <0.0001. 
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Inhibition of SOCE impairs ability of adipocytes to differentiate 
Impaired differentiation of preadipocytes has been shown in obese subjects 
(Isakson et al., 2009). Interestingly, altering [Ca2+]i inhibits differentiation of 
adipocytes (Jensen et al., 2004; Neal and Clipstone, 2002), however to date, it is 
unknown whether store-mediated changes in [Ca2+]i leading to adipocyte 
differentiation is analogous between VAT and Subc AT. To investigate, we first 
blocked SOCE by pretreating cells with SKF and then initiated differentiation. Subc 
AT and VAT SVF adipocytes were differentiated in the continuous presence of 
SKF (10 mM) for 7 days and lipid accumulation was detected by oil-red-O (Figure 
13 A). Oil-red-o stains neutral triglycerides and lipids and the absorbance at 492 
nm can be used to quantify total lipid in sample. As such, treatment with SKF 
significantly reduced the ability of both Subc AT and VAT SVF cells to accumulate 
intracellular lipids (Figure 13 B, D). Expression of PPARg, FABP4, and perilipin is 
absent in undifferentiated preadipocytes, thus measuring their protein expression 
level is a measurement of adipogenesis. In both Subc AT and VAT, treatment with 
SKF blocked nearly all expression of FABP4, perilipin, and PPARg (Figure 13 C, 
E). These results further indicate the involvement of SOCE mediated Ca2+ influx in 
adipocyte differentiation and that it may be necessary for early stages of 
transcriptional regulation. 
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Loss of TRPC1 in adipocytes reduces SOCE  
Since TRPC1 is an active member of SOCE mechanisms and is highly 
expressed in adipocytes, we explored whether TRPC1 is vital to adipocyte 
differentiation. To do this, SVF cells from TRPC1-/- and WT mice were isolated and 
differentiated. Analysis by Ca2+ imaging of both Subc AT cell types (SVF and 
differentiated adipocytes) showed TRPC1-/- cells had a reduction in internal ER 
Ca2+ release (first peak) with the addition of Tg as compared to WT (Figure 14 A-
D). When 1mM external Ca2+ was added, [Ca2+]i in both SVF and differentiated 
TRPC1-/- cells was significantly reduced as compared to WT indicating diminished 
SOCE in TRPC1-/- cells. The TRPC1-like membrane current observed in WT Subc 
SVF adipocytes upon the addition of Tg (1mM) was significantly reduced in Subc 
AT SVF from TRPC1-/- mice (Figure 14 E-G).  Similar results were observed in 
differentiated Subc AT, where loss of TRPC1 significantly decreased Tg-mediated 
Ca2+ currents (Figure 14 H-J). 
To confirm that lack of TRPC1 alters SOCE mechanisms in differentiated 
Sub AT, we depleted internal stores through treatment with angiotensin II, which 
stimulates endogenous G-protein coupled receptors. Addition of angiotensin II 
resulted in a decrease of Ca2+ entry in TRPC1-/- differentiated Subc AT indicating 
that TRPC1 is the functional store/receptor-operated Ca2+ entry (S/ROCE) channel 
in these cells (Figure 15 A, B). Importantly, basal Ca2+ entry (no store depletion) 
was unaltered in adipocytes from WT or TRPC1-/- mice (Figure 15 C, D). 
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Figure 14 Loss of TRPC1 in adipocytes reduces SOCE  
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Figure 14 Loss of TRPC1 in adipocytes reduces SOCE  
Fura-2 traces and quantification of transient increase in [Ca2+]i after addition of 
1 μM Tg and 1 mM Ca2+ to WT  and TRPC1-/- Subc AT SVF (A, B) and 
differentiated Subc AT (C, D). Application of 1 μM Tg induced inward currents 
at −80mV in WT Control and TRPC1-/- Subc AT SVF (E) and differentiated Subc 
AT (H). Respective IV curves of Subc AT SVF (F) and differentiated Subc AT 
(I). Quantification (n = 5 recordings) of current intensity at −80 mV is shown for 
Subc AT SVF in (G) and differentiated Subc AT in (J). Graphs are mean ± SEM, 
significance: *, p < 0.05; **, p < 0.01. 
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Figure 15 Angiotensin II treatment of differentiated Subc AT 
Analog plots of Ca2+ entry upon addition of angiotensin II in a Ca2+ containing 
media from an average of 30-50 cells isolated from WT or TRPC-/- mice are 
shown in B. Quantification (mean ± S.D.) of 340/380 ratio under these 
conditions is shown in B. Basal Ca2+ entry (without store-depletion) from an 
average of 40-50 cells in each condition are shown in C. (D) Quantification 
(mean ± S.D.) of 340/380 ratio. significance: *, p < 0.05; ***,  p < 0.001. 
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Next, isolated VAT from WT and TRPC1-/- mice was evaluated in the same 
manner as the Subc AT experiments. Electrophysiological recordings of 
membrane currents indicate TRPC1 currents were significantly reduced in both 
VAT SVF TRPC1-/- cells (Figure 16 A-C) and differentiated TRPC1-/- VAT (Figure 
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Figure 16 SOCE currents in visceral adipocytes reduced  
Application of 1 μM Tg induced inward currents at −80mV in WT Control and 
TRPC1-/- VAT SVF cells (A) and differentiated VAT (D). Respective IV curves 
for each cell type are shown for VAT SVF (B) and differentiated VAT (E). 
Quantitation (n = 5 recordings) of current intensity at −80 mV for VAT SVF (C) 
and differentiated VAT (F). Graphs are mean ± SEM, significance: *, p < 0.05. 
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16 D-F). Interestingly, after differentiation, the Ca2+ current in TRPC1-/- VAT was 
more inwardly rectifying and showed properties similar to ORAI1 currents. Analysis 
of Ca2+ influx upon treatment with Tg showed a decrease in internal ER Ca2+ 
release in TRPC1-/- differentiated VAT adipocytes but not in undifferentiated VAT 
SVF (Error! Reference source not found. A-D). Similar to Subc AT, addition of 
external Ca2+ resulted in a reduction in Ca2+ influx in both types (SVF and 
differentiated) of TRPC1-/- VAT as compared to WT control (Error! Reference 
source not found. A-D). Combined data from Subc AT and VAT indicates SOCE 
mechanisms in SVF and differentiated adipocytes from both depots are impaired 
due to the loss of TRPC1.   
Protein expression analysis of numerous Ca2+ regulating proteins in WT and 
TRPC1-/- Subc AT and VAT was performed to rule out compensation for the lack 
of TRPC1. As shown in Figure 18, an increase in STIM1 and TRPC5 expression 
was observed in Subc AT of TRPC1-/- mice which is consistent with our previous 
Figure 17 Ca2+ channel 
expression of WT and 
TRPC1-/- Subc AT and VAT 
Western blot of TRPC5, 
TRPC3, STIM1, ORAI3, and 
ORAI1 protein expression of 
WT and TRPC1-/- Subc AT 
and VAT tissue lysates. 
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work (Krout et al., 2017). However, no significant change in either STIM1 or 
TRPC5 was observed in VAT. It is known that TRPC1 forms a C1/C5 
heterotetramer with TRPC5 (Shi et al., 2012), however loss of TRPC1 would make 
TRPC5 inactive and thus not compensate for the loss of TRPC1 in TRPC1-/- mice.  
Interestingly, increasing STIM1 expression has been shown to have no effect on 
normal SOCE mechanisms (Gwozdz et al., 2012). The remaining Ca2+ channels, 
TRPC3, ORAI1, and ORAI3, showed no change in protein expression between 
WT and TRPC1-/- in either tissue type (Figure 18). This indicates the lack of TRPC1 
function in adipose tissue most likely does not increase Ca2+ entry by altering 
protein expression of other Ca2+ channels.   
 
Lack of TRPC1 mediated Ca2+ influx reduces ability to differentiate 
We next investigated whether a lack of TRPC1 would alter the ability of 
Subc and VAT SVF cells to differentiate. Analysis of lipid accumulation via oil-red-
o in WT and TRPC1-/- adipocytes after seven days of differentiation revealed a 
significant reduction in total lipid when TRPC1 is nonfunctional in Subc AT (Figure 
19 A, B) and VAT (Figure 19 C, D). This same phenomenon is replicated in the 
protein expression of perilipin, FABP4, and PPARg which were also reduced in 
TRPC1-/- Subc AT (Figure 20 A, B) and VAT (Figure 20 C, D) as compared to WT. 
To offset the reduced ability to increase [Ca2+]i of TRPC1-/- cells, Subc AT and VAT 
SVF cells from WT and TRPC1-/- mice were differentiated with a 2 and 4 fold 
greater extracellular Ca2+ concentration than basal. In WT and TRPC1-/- Subc AT 
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cells, increasing extracellular Ca2+ to both 2 and 4 fold produced no change in lipid 
accumulation (Figure 19 A, B). No difference in lipid accumulation was observed 
when extracellular Ca2+ concentrations were increased in TRPC1-/- VAT, however 
WT VAT adipocytes differentiated with a 4 fold greater extracellular Ca2+ 
concentration had significantly less lipid than basal (Figure 19 C, D). We next 
assessed whether the reduction in lipid accumulation due to increased 
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extracellular Ca2+ was replicated in adipogenetic protein expression. In WT Subc 
AT there was a significant reduction in expression of PPARg and perilipin when 
extracellular Ca2+ concentration was raised to 4-fold, however the expression of 
FABP4 did not seem to be altered in either tissue type (Figure 20 A, B). Raising 
extracellular Ca2+ concentrations in TRPC1-/- Subc AT and VAT had similar results 
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Figure 18 Loss of TRPC1 in adipocytes reduces ability to differentiate 
Oil-red-o staining of WT and TRPC1-/- Subc AT (A) and VAT (C) differentiated in 
1x (basal), 2x, or 4x extracellular Ca2+ for 7 days. Quantification of eluted oil-red-
o stain at 492nm of Subc AT (B) and VAT (D). Graphs are mean ± SEM, 
significance: *, p < 0.05; **, p < 0.01. 
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to WT with the greatest expression observed at basal for PPARg and perilipin. 
Together these results reveal TRPC1 to be a functional partner in SOCE in both 
Subc AT and VAT differentiation and may necessary for the early stages of 
differentiation to promote PPARg expression. Further, reduced Ca2+ influx due to 
loss of TRPC1 cannot be supplemented by raising extracellular Ca2+ 
concentrations. Finally, increased extracellular Ca2+ concentrations diminish lipid 
accumulation and PPARg expression in WT Subc AT and VAT, however no 
substantive change was observed in FABP4 expression.   
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Figure 19 Adipogenetic protein expression in TRPC1-/- adipocytes 
diminished 
Western blot of PPARg, FAPB4, and perilipin protein expression of WT and 
TRPC1-/- Subc AT (A) and VAT (B) differentiated in 1x (basal), 2x, or 4x 
extracellular Ca2+. 
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TRPC1-/- mice have increased fatty-acid desaturation index  
and adiposity with age 
We have determined that lack of TRPC1 leads to a reduction in lipid 
accumulation and differentiation in an ex vivo model, leading us to next investigate 
whether dysfunctional TRPC1 channels could alter overall body composition. Body 
mass composition analysis was performed on TRPC1-/- and WT mice aged 13-15 
months, which resulted in a more than two-fold increase in the ratio of total fat to 
body weight in TRPC1-/- mice as compared to age matched WT mice (Figure 21 
A). Visually this difference in body composition can be seen in Figure 21 B where 
9-month-old TRPC1-/- mice have increased Subc AT and VAT volume as 
compared to its WT counterpart. Interestingly, the increase in total fat observed in 
TRPC1-/- mice did not translate to an increase in their overall body weight. Within 
a majority of age groups, no significant difference in the overall body weight was 
observed in TRPC1-/- mice when compared with WT mice, however younger 
TRPC1-/- mice, aged 0-3 months, had reduced overall body weight (Figure 21 C). 
In all ages, TRPC1-/- mice did have lower organ weights (such as hearts and 
kidneys), which were reduced in size regardless of age and may attribute to the 
increase in adiposity without an increase in overall body weight (Figure 21 D).  
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Figure 20 TRPC1-\- mice have increased adiposity with age 
(A) Body fat mass measured by EchoMRI and calculated by dividing the fat 
weight by total body weight of mice aged 13-15 months n=9-11. (B) Exposed 
Subc AT and Visc AT of WT and TRPC1-/- male mice aged 9 months. (C) Total 
body weight of WT and TRPC1-/- mice grouped by 3-month increments of age. 
(D) Ratio of organ to total body weight of WT and TRPC1-/- mice. Graphs are 
mean ± SEM, significance: *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
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Obesity is most easily characterized by excess adipose accumulation, 
however excess lipids are also stored in other organs such as the liver, muscle, 
and pancreas. To determine whether the increased adiposity observed in TRPC1-
/- mice effected important metabolic organs, fatty acid composition of liver samples 
from WT and TRPC1-/- mice was calculated using gas chromatography/mass 
spectrometry (GC/MS). Liver fatty acid composition was relatively the same 
between WT and TRPC1-/- samples with the exception of mono and 
polyunsaturated fatty acids which were increased in TRPC1-/- (Figure 22 A). These 
included palmitoleic acid (16:1), oleic acid (18:1), linoleic acid (18:2), eicosenoic 
acid (20:1), and eicosadienoic acid (20:2). Increased ratios of monounsaturated to 
saturated fatty acids (desaturation index), particularly palmitoleic to palmitic acid 
(16:1/16:0) and oleic to stearic acid (18:1/18:0), has been correlated to obesity and 
insulin resistance (Jeyakumar et al., 2009; Pinnamaneni et al., 2006; Yee et al., 
2014). Within our study, we found that both ratios were increased in liver samples 
from TRPC1-/- mice (Figure 22 B), indicating increased activity of Stearoyl CoA 
desaturase 1. Together these data suggest that the loss of TRPC1 function 
attributes to an increase in the accumulation of adipocytes, but not overall weight, 
and a liver lipid profile similar to an obese phenotype.  
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Figure 21 Desaturation of liver fatty acids increased in TRPC1-/- mice 
Composition of liver fatty acids of WT and TRPC1-/- mice aged 4 months 
determined by gas chromatography/mass spectrometry (GC/MS) n=5. (B) Fatty 
acid desaturation index (16:1/16:0 and 18:1/18:0) calculated from (A). Graphs 
are mean ± SEM, significance: *, p < 0.05. 
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Conclusion 
The incidence of obesity-associated diseases such as type II diabetes, 
hypertension, cardiovascular risk, and cancer has increased drastically worldwide. 
Consequently, scientific inquiry into the mechanisms underlying adipose tissue 
development and the pathology of obesity has gained interest. Though an array of 
metabolic disorders are linked to alterations of Ca2+ homeostasis (Arruda and 
Hotamisligil, 2015), the study of Ca2+ within adipose tissue has been 
underrepresented. Evidence suggests adipose tissue [Ca2+]i is partly mediated by 
SOCE (El Hachmane et al., 2018), thus we focused on the identification of the 
endogenous Ca2+ entry channel and establish its role in adipocyte function. In our 
study, we identify TRPC1 as a major regulator of adipocyte energy metabolism 
through mediation of adipocyte differentiation. 
SOCE was first identified as a major component of non-excitable cells 
(Parekh and Putney, 2005), but further research has identified SOCE within a 
multitude of tissue types. This knowledge has unveiled it to be a ubiquitous Ca2+ 
signaling pathway which regulates numerous cellular functions including those 
connected with diabetic complications (Chaudhari and Ma, 2016). Identification of 
SOCE mechanisms within adipocytes may lead to a better understanding of the 
onset of obesity and metabolic disorders and reveal therapeutic possibilities. 
Within our study, Ca2+ entry was demonstrated to have SOCE properties that could 
effectively be reduced by the addition of a non-specific Ca2+ entry channel blocker 
SKF in both Subc AT and VAT. This indicates a similar mechanism for Ca2+ entry 
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influx between the tissue types. Furthermore, the current properties observed and 
blocked by SKF were similar to that of a TRPC1 channel (Liu et al., 2003; Selvaraj 
et al., 2012). The role of SOCE and the specific Ca2+ channel involved within Subc 
AT and VAT was further confirmed using adipose tissue with a genetic ablation of 
TRPC1. Loss of TRPC1 showed a significant decrease in Ca2+ entry upon 
treatment with Tg in SVF and differentiated adipocytes of both tissue types. 
Importantly, although ORAI1 was present, it was not able to compensate for the 
loss of TRPC1, suggesting that the major Ca2+ entry channel in adipocytes is 
mediated via TRPC1. Interestingly, loss of ORAI1 has been shown to modulate 
immune function (Ahuja et al., 2017), which also plays a vital role in obesity. Within 
our study, TRPC5 expression is increased upon adipocyte differentiation; however 
as TRPC1 forms C1/C5 heterotetramers (Shi et al., 2012), loss of TRPC1 would 
inactivate TRPC5 and thus could not compensate in TRPC1-/- mice. Upon 
differentiation, a higher amplitude of TRPC1-like current in both Subc AT and VAT 
was observed which is most likely attributable to the more than 2-fold upregulation 
of TRPC1 expression. In addition, current properties in differentiated VAT cells, 
especially in TRPC1-/-, were similar to that observed with ORAI1. This suggests 
that ORAI1 could play a role in VAT tissues, however further research is needed 
to fully establish the role of ORAI1 in these cells. 
Adipocyte differentiation is a complex process and dysregulation can lead 
to lipid accumulation and altered energy and metabolic regulation. Though the 
process is not fully understood, several studies have identified Ca2+ dependency 
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within adipocyte differentiation (Jensen et al., 2004; Neal and Clipstone, 2002; 
Pramme-Steinwachs et al., 2017; Shi et al., 2000). Our study is the first to use both 
genetic and pharmacological inhibitors to show that Ca2+ entry via TRPC1 is critical 
for adipocyte differentiation. Our results are consistent with other studies that have 
identified modulators such as STIM1 expression changes (Graham et al., 2009) 
and calcineurin, a calcium and calmodulin dependent serine/threonine protein 
phosphatase, activation (Neal and Clipstone, 2002) as important for the maturation 
of adipocyte precursor cells. Use of SKF to block store-mediated Ca2+ entry during 
differentiation not only impaired lipid droplet formation in WT Subc AT and VAT 
SVF, but also inhibited the expression of lipid mobilization proteins FABP4 and 
perilipin and transcription factor PPARg.  
The transcription factor PPARg is essentially expressed during early 
differentiation stages and regulates a number of adipocyte marker genes, including 
FABP4 and perilipin (Farmer, 2006; Wu et al., 1999). Here we show blockage of 
Ca2+ influx by SKF suppresses PPARg expression indicating Subc AT and VAT 
SVF may be unable to induce the initial processes of differentiation when SOCE 
is inhibited. Suppression of SOCE by TRPC1 loss, as seen in TRPC1-/- Subc and 
VAT cells, resulted in a reduction but not a complete impairment of lipid 
accumulation in both tissue types. Correspondingly, TRPC1-/- Subc and VAT 
differentiated adipocyte expression of FABP4, perilipin, and PPARg was reduced 
when compared to WT indicating TRPC1 may be involved in the initial stages of 
PPARg mediated differentiation. In the next chapter, we will discuss adipocyte size 
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more, however it was found that TRPC1-/- had a lower quantity of large adipocytes 
in Subc AT and VAT as compared to WT which may be attributed to partial 
differentiation dysfunction.  
In contrast to Ca2+ blockage, continuous exposure to high external Ca2+ has 
been shown to inhibit preadipocyte differentiation (Jensen et al., 2004) and block 
adipocyte lipid accumulation and expression of adipogenic transcription factors 
(Pramme-Steinwachs et al., 2017; Shi et al., 2000). The relationship between 
serum and extracellular Ca2+ is tightly regulated and kept at relatively similar 
concentrations (Hofer and Brown, 2003). Interestingly, increased serum Ca2+ has 
been associated with obesity (Ren et al., 2013) and type II diabetes (Lorenzo et 
al., 2014) and could denote a correlative increased extracellular Ca2+ 
concentration. Within our study, increasing normal extracellular Ca2+ 
concentrations by 4-fold decreased differentiation in WT VAT but had no effect on 
Subc AT. Interestingly, a slight difference in lipid accumulation was observed 
between WT Subc AT and WT VAT at all Ca2+ concentrations. Subc AT is known 
to have greater differentiation potential and proliferative ability when compared to 
VAT (Baglioni et al., 2012), which most likely explains the differences observed in 
WT Subc and VAT lipid accumulations. Subc AT was able to overcome the 
inhibitory effect of the increased extracellular Ca2+ to sustain lipid accumulation, 
whereas VAT adipocytes were not. Though increasing extracellular Ca2+ 
concentrations had no effect on lipid accumulation in Subc AT, protein expression 
of key differentiation factors reduced when Ca2+ increased which is similar to that 
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of VAT. This may confirm what other studies have shown that extended exposure 
to high Ca2+ concentrations inhibits differentiation of adipocytes, particularly in 
VAT.  
Impaired adipogenesis can lead to a multitude of different outcomes with 
the most common being an unhealthy expansion of adipose tissue. This 
phenomenon is generally seen in adult obesity which is hypertrophic in nature and 
the reason why PPARg agonists such as TZDs are useful in obesity (Choe et al., 
2016). Interestingly, hypertrophic adipocytes from obese mice were observed to 
have increased Ca2+ deposits surrounding lipid droplets possibly indicating 
increased [Ca2+]i  (Giordano et al., 2013). Within our study, TRPC1-/- mice exhibited 
increased adipose tissue accumulation as they aged; however overall body weight 
did not significantly increase relative to WT mice. This increase in adipose 
accumulation could be due to dysfunctional adipose differentiation which in time 
results in a hypertrophic expansion. Another important finding was that organ 
weights were reduced, which could be due to the fact that TRPC1 has been shown 
to play a critical role in cell proliferation (Alonso-Carbajo et al., 2017) and may be 
a reason for the increase in adipose accumulation without an increase in body 
weight.  
Though differentiation may contribute to the increased adiposity, there 
could be other explanations including a reduction of lipolysis. If this is the case, 
fatty acids are not mobilized from triacylglycerol stores properly, which in turn 
would expand adipose tissue volume over time. Furthermore, deletion of FABP4 
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has been shown to reduce lipolysis and FABP4 knockout mice have increased 
white AT mass on a high-fat diet (Hotamisligil et al., 1996). In our model, lack of 
TRPC1 may inhibit the expression FABP4 thus reducing lipolysis. Another 
possibility is that TRPC1 could be involved in store-operated Ca2+ entry necessary 
to induce lipolysis. Lack of store-operated Ca2+ entry proteins have shown to 
disrupt regulators of lipid metabolism and results in increased organ lipid droplet 
formation (Maus et al., 2017). Together, these results indicate that SOCE via 
TRPC1 may be involved in the initial stages of adipocyte differentiation of both 
Subc AT and VAT and result in increased adipose tissue volume over time, 
however more research needs to be done to determine the exact mechanism. 
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CHAPTER IV 
THE TRPC1 Ca2+-PERMEABLE CHANNEL INHIBITS  
EXERCISE-INDUCED PROTECTION AGAINST HIGH-FAT DIET-INDUCED 
OBESITY AND TYPE II DIABETES 
 
Introduction 
Obesity is a hallmark of metabolic syndrome and a key feature of obesity is 
the disruption of metabolic homeostasis leading to excess adipose accumulation 
(Blüher, 2009; Claycombe et al., 2013; Claycombe et al., 2016; Claycombe et al., 
2015), thus therapeutic targeting of proteins involved in these pathways could be 
essential for slowing or preventing the development of obesity and obesity-related 
health problems, including insulin resistance and type II diabetes. As shown in 
Chapter one along with other reports (Sukumar et al., 2012), TRPC1 gene 
expression is induced in differentiated adipocytes, yet no data are currently 
available on whether TRPC1 has a role in adipocyte energy metabolism regulation 
by altering mitochondrial energy oxidation, adipocyte lipid storage and size, and 
adipose tissue weight.  
A possible way that TRPC channels may control energy metabolism and 
adiposity is by acting as sensors for chemical factors necessary in adipocyte 
biology (Sukumar et al., 2012). Dietary saturated fat intake promotes obesity and
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 type II diabetes (Holzer et al., 2011) whereas n-3 polyunsaturated fatty acids 
(PUFAs) mainly found in fish oil produce opposite effects (Kuda et al., 2016; 
Ouguerram et al., 2006). Treatment of human embryonic kidney cells (HEK 293) 
with n-3 PUFAs such as linolenicdocosahexaenoic, and eicosapentaenoic acids 
inhibit Ca+2 entry via TRPC5 homomeric and TRPC1–TRPC heteromeric 
channels. Interestingly, the PUFA concentrations used in this study were within the 
physiologically achievable range of the human diet (Sukumar et al., 2012). 
Whether high dietary saturated fat intake modulates adipocyte energy metabolism 
via TRPC1-mediated signaling is not yet known. 
Moreover, experimental evidence indicates that several TRP channels play 
an important role in the onset of diabetes (Graham et al., 2009; Hu et al., 2009; 
Sabourin et al., 2015) or diet-induced obesity (Ye et al., 2012); however, the role 
of TRPC1 in these circumstances is not yet established. Exercise regulates body 
energy stores and insulin resistance by reducing adipocyte size and lipid content 
(Craig et al., 1981; Gollisch et al., 2009) and by regulating serum glucose 
homeostasis through inducing GLUT4 (glucose transporter type 4) protein 
expression (Stanford et al., 2015). Interestingly, treadmill running prevents Ca+2 
dysregulation and diabetic dyslipidemia in high-fat (HF) fed swine (Witczak et al., 
2006). TRPC1 knock-out (KO or TRPC1-/-) mice with attenuated Ca+2 entry (Liu et 
al., 2007) experienced reduced muscular endurance due in part to reduced force 
production and a greater rate of muscle fatigue (Zanou et al., 2010). However, 
whether a HF diet could exacerbate reduced exercise tolerance in TRPC1 KO mice 
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or contribute to mitochondrial energy metabolism dysfunction is also not yet 
known. Currently, no other studies have investigated the effects of dietary HF and 
exercise on adipocyte energy metabolism alteration via TRPC1 protein regulation 
of intracellular Ca+2 homeostasis.  
The regulation of adipocyte size and longevity may also be an area of 
involvement for TRPC1. It has been shown that increased subcutaneous adipocyte 
size is predictive to the development of insulin resistance and type II diabetes 
(Lundgren et al., 2007; Skurk et al., 2007; Weyer et al., 2000). Further, there is a 
negative correlation between adipocyte size and insulin sensitivity and a positive 
correlation with proinflammatory adipocytokine secretion (Lönn et al., 2010; Yang 
et al., 2012). It has also been reported that adipose mass along with differentiation 
is regulated by a process called autophagy (Singh et al., 2009; Zhang et al., 2009). 
Interestingly, there is an increase in autophagy in obese subjects, particularly in 
VAT depots (Kovsan et al., 2011) along with an increase in apoptotic pathways 
(Alkhouri et al., 2010; Sorisky et al., 2000). Autophagy deficient mice exhibit 
reduced efficiency in adipogenesis (Baerga et al., 2009) with altered morphology 
(Wang and Peng, 2012).  
Autophagy is described as a cellular process responsible for the delivery of 
proteins or organelles to lysosomes for degradation. Cells encountering stressful 
situations can either try to survive using the beneficial process of autophagy or by 
activating a programmed cell death program called apoptosis (Decuypere et al., 
2011; East and Campanella, 2013; Kondratskyi et al., 2013). To date, three types 
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of autophagy exist; macroautophagy, microautophagy and chaperone-mediated 
autophagy (CMA) (Decuypere et al., 2011; Kato et al., 2014). Cellular stress 
conditions including nutrient starvation, hypoxia conditions, invading microbes, 
and tumor formation have been shown to induce autophagy and allows cell survival 
in these stressful or pathological situations (Kato et al., 2014). In addition, 
autophagy also recycles existing cytoplasmic components that are required to 
sustain vital cellular functions (Zhang and Calderwood, 2011). Although autophagy 
and apoptosis are mechanistically different cellular processes, there are some 
common regulatory proteins that intervene in both, such as the anti-apoptotic/anti-
autophagy regulators B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-X large (Bcl-
XL) and Ca2+ signaling. Bcl-2 and Bcl-XL are known to inhibit apoptosis by binding 
to Bcl-2–associated X (Bax) or Bcl-2 homologous antagonist/killer (Bak) but also 
suppress autophagy by binding to Beclin-1 (Lindqvist et al., 2014).  
Intracellular Ca2+ is known to play an important role in autophagy in both 
basal and induced models (Cárdenas et al., 2010; Høyer-Hansen et al., 2007), 
however the mechanism by which Ca2+ regulates autophagy remains controversial 
(Decuypere et al., 2011). This is due to the previous studies showing both an 
activating and inhibitory role in autophagy (Cárdenas et al., 2010; Su et al., 2013). 
A commonality to these different studies is the focus on IP3R which is important 
for SOCE mechanisms (Figure 23). With regards to channel identity, our laboratory 
has shown in numerous studies indicating TRPC1 has a role in cell survival and 
apoptosis (Bollimuntha et al., 2006; Pani et al., 2006; Selvaraj et al., 2009). 
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Recently our lab has shown that TRPC1 is a key regulator in hypoxia and nutrient 
depletion dependent autophagy (Sukumaran et al., 2015). Specifically, that an 
increase in intracellular Ca2+ via TRPC1 regulates autophagy, thereby preventing 
cell death in two morphologically distinct cells lines (Sukumaran et al., 2016).  
The present study investigated the involvement of TRPC1 in diet-induced 
obesity and type II diabetes. Additionally, regulation of adipocyte formation under 
normal-fat (Stanford et al., 2015) or HF diet and control cage or voluntary exercise 
conditions was also evaluated to determine how optimal dietary treatments and 
exercise promote a healthy body weight. Our data indicate that TRPC1 KO mice 
fed a HF diet and exercised are protected from diet-induced obesity and type II 
diabetes risk due to decreased autophagy and increased apoptosis resulting from 
loss of Ca+2 influx through TRPC1.  
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Figure 22 Role of intracellular Ca2+ and Ca2+ permeable channels in 
autophagy 
Schematic diagram showing intracellular Ca2+ and Ca2+ permeable channels 
in the control of autophagy. Stimulation of Ca2+ permeable channels are 
activated both excited and non-excited Ca2+ channels and results in release of 
the store Ca2+ from the ER and Golgi bodies. These results in ER stress and 
disturbed Ca2+ homeostasis in the cells; which via various Ca2+ regulated 
proteins like ERK, calpains, cAMP regulates the autophagy processes. 
Reprinted from “Functional role of TRP channels in modulating ER stress and 
Autophagy” by P. Sukumaran, 2016, Cell Calcium, 60, 123-132. Copyright 
2016 by Elsevier. Reprinted with permission. 
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Results 
 
Body fat mass is decreased in TRPC1 KO mice fed a HF diet and exercised 
For 12 weeks, mice were fed diets containing either 16% (normal-fat, NF) 
or 45% fat (high-fat, HF) for 12 weeks and subjected to voluntary wheel running 
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Figure 23 TRPC1 KO mice fed a HF diet and exercised have decreased 
body fat mass 
A and B, body weight was measured at week 0 (A) and week 12 (B). C, body 
weight change was calculated by dividing the body weight at week 12 by the body 
weight at week 0. D and E, body fat mass was measured by EchoMRI at week 0 
(D) and week 12 (E). F, body fat change was calculated by dividing the fat weight 
at week 12 by the fat weight at week 0. Data are presented as mean ± S.D., n = 
6–8. Significant (p < 0.05) effects from 3-way ANOVA are indicated by + (mouse 
type), × (diet), and # (exercise). 
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exercise. TRPC1 KO mice had lower body weight (Figure 24 A) and body fat mass 
(Figure 24 D) at the start of the study and after 12 weeks of diet and exercise 
(Figure 24 B, E) when compared to WT mice. However, when calculated as a fold 
change, there was no change in body weight when comparing WT to TRPC1 KO 
mice (Figure 24 C). Within groups, change in body fat mass was significantly 
decreased in TRPC1 KO mice fed a HF diet and exercised compared to WT mice 
fed a HF diet and exercised (Figure 24 F). Furthermore, TRPC1 KO mice fed a HF 
diet and exercised had less change in body fat mass than TRPC1 KO mice fed a 
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Figure 24 Daily food intake and exercise is unaltered 
Food consumption and exercise were measured biweekly from WT and TRPC1 
KO mice over the course of 12 weeks. Data are presented as means ± S.D., n = 
7-8. Significant (p < 0.05) effects from 3-way ANOVA are indicated by + (mouse 
type), × (diet), and # (exercise). 
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HF diet and subjected to sedentary cage activity (Figure 24 F). Though food intake 
variation was influenced by the type of mouse and an exercise x diet interaction, 
altered body composition was not a result of group differences in food consumption 
or exercise (Figure 25 A, B). As we saw from the data presented in Chapter One, 
TRPC1 is the major Ca2+ entry channel in adipocytes and the new data presented 
here shows that loss of TRPC1 decreases obesity risk in HF fed mice that exercise. 
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Figure 25 TRPC1 KO mice fed a HF diet and exercised have reduced insulin 
resistance 
A–D, blood glucose (A and B), plasma insulin (C), and calculated homeostatic 
model assessment of insulin resistance (D) were measured from WT and TRPC1 
KO mice fasted overnight after 12 weeks of diet and exercise. Data are presented 
as mean ± S.E. (A) or S.D. (B–D), n = 7–8. Significant (p < 0.05) effects from 3-
way ANOVA are indicated by + (mouse type), × (diet), and # (exercise). 
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TRPC1 KO mice fed a HF diet and exercised are protected  
from type II diabetes risk 
The data provided above show an important role for TRPC1 in the onset of 
metabolic syndrome. Thus, glucose concentrations were next evaluated under 
these conditions. Maximum blood glucose concentrations occurred 15-30 min after 
intraperitoneal injection of glucose in all groups (Figure 26 A). Interestingly, overall 
TRPC1 KO mice had reduced blood glucose concentrations as compared to WT, 
however, within groups, blood glucose concentrations were only decreased in 
TRPC1 KO mice fed a HF diet and exercised when compared to WT mice fed a 
HF diet and exercised (Figure 26 B). Similarly, serum insulin concentrations were 
overall decreased in TRPC1 KO mice and the group TRPC1 fed a HF diet and 
exercised was decreased as compared to WT mice fed a HF diet and exercised 
(Figure 26 C). Using a homeostatic model assessment of insulin resistance 
(HOMA IR) to assess the fasting blood glucose/insulin ratio, we found that, once 
more, TRPC1 KO mice were overall less insulin resistant than WT and the TRPC1 
KO group fed a HF diet and exercised were less insulin resistant than WT mice fed 
a HF diet and exercised (Figure 26 D). It was confirmed that this difference was 
not due to altered expression of GLUT4 in the subcutaneous adipose tissue 
(Figure 27 A) or skeletal muscle (Figure 27 B). These studies suggest that loss of 
TRPC1 decreases insulin resistance and risk of diabetes thereby inhibiting 
metabolic syndrome.  
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Figure 26 GLUT4 expression is unaltered in Subc AT and skeletal 
muscle 
A and B, GLUT4 expression in subcutaneous adipose tissue (A) and hind 
leg biceps femoris skeletal muscle (B) was measured from WT and TRPC1 
KO mice following 12 weeks of diet and exercise. Data are presented as 
mean ± S.D., n = 7–8. 
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Adipocyte numbers are decreased in  
TRPC1 KO mice fed a HF diet and exercised 
To establish if adipocyte number or size is varied under these conditions, 
we counted the number of adipocytes present in adipose tissue depots and 
determined the adipocyte size. In the subcutaneous and visceral adipose tissue 
depots, adipocytes with size ranges of 80-160 μm were decreased in TRPC1 KO 
mice fed a HF diet and exercised compared to WT mice fed a HF diet and 
exercised but not in the smaller size range of 20-80 μm (Figure 28). In addition, 
TRPC1 KO mice fed a HF diet and subjected to sedentary cage activity had 
decreased adipocytes from 160-200 μm when compared to WT mice fed a HF diet 
and subjected to sedentary cage activity (Figure 28) This data suggests that loss 
of TRPC1 combined with a HF diet decreases the number of larger adipocytes, 
which could explain the decreased fat mass observed in Figure 24. 
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Figure 27 TRPC1 KO mice fed a HF diet and exercised have fewer 
adipocytes 
Adipose tissue harvested from WT and TRPC1 KO mice following 12 weeks of 
diet and exercise was measured by a Multisizer. Data are presented as mean 
± S.D., n = 6–8. Significant (p < 0.05) effects from 3-way ANOVA are indicated 
by + (mouse type), × (diet), and # (exercise). 
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Autophagy marker expression is decreased while apoptosis marker 
expression is increased in TRPC1 KO mice fed a HF diet and exercised 
To determine whether reduced adipocyte numbers in adipose depots of 
TRPC1 KO mice fed a HF diet and exercised seen in Figure 28 were due to 
apoptosis or reduced differentiation of adipocytes, we measured mRNA of key 
markers for adipogenesis (PPARγ), beiging (FGF21), hypoxia (HIF1α), and 
autophagy (MAP1LC3A, BECN1). Though there was no altered mRNA expression 
of PPARγ, FGF21, HIF1α, or BECN1 in subcutaneous adipose tissue (Figure 30 
A-D), expression of the autophagy marker MAP1LC3A was decreased (as 
indicated by an increased Ct value) in TRPC1 KO mice fed a HF diet and exercised 
compared to WT mice fed a HF diet and exercised (Figure 29 A). To confirm that 
our mRNA expression was replicated on the protein level, we examined protein 
expression of autophagy (LC3A, p62) and apoptosis (Bax, Bcl-xl) regulating 
proteins in WT and KO mice fed a HF diet and exercised. LC3A expression was 
decreased along with an increase in p62 expression in samples from TRPC1 KO 
mice that were fed a HF diet and exercised when compared with WT mice fed a 
HF diet and exercised indicating a deficiency in autophagy (Figure 30 B, C). 
Conversely, increased expression of Bax and an increased Bax to Bcl-xl ratio, 
which is an indication of increased apoptosis, was observed in the TRPC1 KO 
mice fed a HF diet and exercised compared to WT mice fed a HF diet and 
exercised (Figure 29 B-D). Together, these results suggest that loss of TRPC1 
decreases autophagy, a survival mechanism, and increases apoptosis, which 
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could promote loss of larger adipocytes. In addition, loss of TRPC1 significantly 
decreased phosphorylation of ERK2, whereas no change in the phosphorylation 
of ERK1 and AMPK was observed (Figure 31). These data further indicate that 
loss of TRPC1 inhibits ERK2 phosphorylation, which has been shown to interact 
with ATG proteins and thus could modulate autophagy in these cells.  
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Figure 28 Autophagy marker expression is decreased whereas apoptosis 
marker expression is increased in TRPC1 KO mice fed a HF diet and exercised 
A, MAP1LC3A mRNA expression was measured from subc adipose tissue taken 
from WT and TRPC1 KO mice following 12 weeks of diet and exercise. Data are 
presented as mean ± S.D., n = 6–8. B, subc adipose tissue from WT and TRPC1 
KO mice fed a HF diet and exercised was resolved and analyzed by Western 
blotting using antibodies labeled in the figure. Quantification of each protein is 
shown in C. Data are presented as mean ± S.D., n = 7–11. D, ratio of Bax/Bcl-xl is 
presented as a fold increase of TRPC1 KO over WT values.  
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Figure 29 Expression of markers for adipogenesis, beiging, and 
hypoxia were unaltered in subcutaneous adipose tissue 
mRNA expression of PPARγ (adipogenesis) (A), FGF21 (beiging) (B), 
HIFIα (hypoxia) (C), and BECN1 (autophagy) (D) was measured from 
subcutaneous adipose tissue taken from WT and TRPC1 KO mice 
following 12 weeks of diet and exercise. Data are presented as means ± 
S.D., n = 6-8.  
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Figure 30 Reduced ERK2 phosphorylation observed in in TRPC1 KO 
mice fed a HF diet and exercised 
Subc adipose tissue isolated from WT and TRPC1 KO mice fed a HF diet and 
exercised was resolved on SDS-PAGE gels and analyzed using different 
antibodies as labeled in the figure with quantification of the phosphorylated to 
non-phosphorylated form of each protein. Data are presented as mean ± S.D., 
n = 5.  
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Conclusion 
This study is the first to show that TRPC1 KO mice that exercise are 
protected from HF diet-induced obesity and type II diabetes risk due to decreased 
adipose tissue mass and adipocyte number as a result of reduced autophagy and 
increased apoptosis. Thus, in combination, exercise, HF diet, and loss of TRPC1 
reduce adiposity through a yet undefined mechanism. Given that TRPC1 is 
involved in Ca2+ entry following depletion of internal Ca2+ stores in the ER, TRPC1 
KO results in decreased Ca2+ entry in a variety of cell types including adipocytes 
(Sukumar et al., 2012), skeletal muscle (Zanou et al., 2010), neuronal (Fiorio Pla 
et al., 2005), intestinal epithelial cells (Rao et al., 2006), and salivary glands (Liu 
et al., 2007; Liu et al., 2000). Thus, based on our data, it is probable that reduced 
Ca2+ entry due to TRPC1 KO is influenced further by HF diet and exercise, 
suggestive of a relationship between Ca2+ entry, diet, and exercise. Although 
expression of Orai1 and STIM1 was observed in adipocytes, the properties of the 
endogenous channel was similar to that observed with TRPC1-mediated ISOC (Liu 
et al., 2007; Liu et al., 2000) and not as observed with ICRAC channels (Peinelt et 
al., 2006; Yuan et al., 2009). Similarly, the increased expression of TRPC5 in 
adipocytes did not alter Ca2+ influx as current-voltage recordings were distinctly 
different from TRPC5 homologs and TRPC1/TRPC5 heteromeric channels would 
be non-functional due to the loss of TRPC1 function (Strübing et al., 2001; Wu et 
al., 2010). Furthermore, TRPC1 KO mice showed exercise-mediated inhibition of 
adiposity and decreased insulin resistance in the absence of TRPC1 suggesting 
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that TRPC1 might be the dominant Ca2+ channel in these cells. However, additional 
studies will be needed to determine the role of Orai1 channels in exercise-
mediated regulation of metabolic syndrome.  
The present study demonstrated that fat mass was reduced in TRPC1 KO 
mice compared to WT mice following twelve weeks of HF diet and exercise. 
Similarly, previous studies have shown that TRPV4 KO mice (another Ca2+ entry 
channel from the TRPV family) are also protected from obesity and metabolic 
dysfunction with exposure to HF diet (Ye et al., 2012) suggesting that Ca2+ 
channels negatively regulate obesity. This is in contrast to the expectations that 
HF-fed mice develop obesity and glucose intolerance (Kalupahana et al., 2010) 
since TRPC1 KO mice fed a HF-diet and exercised were less insulin resistant than 
their WT counterpart, indicative of protection from type II diabetes risk, yet GLUT4 
expression was unaltered in hind leg biceps femoris skeletal muscle or 
subcutaneous adipose tissue. Furthermore, the number and size of subcutaneous 
and visceral adipocytes are decreased in TRPC1 KO mice compared to WT mice 
when fed a HF diet and exercised. Because TRPC1 plays a key role in cell survival 
and apoptosis (Bollimuntha et al., 2006; Pani et al., 2006; Selvaraj et al., 2009), it 
was hypothesized that TRPC1 KO mice would alter expression patterns of key 
markers for adipogenesis, apoptosis, or autophagy in subcutaneous adipose 
tissue. TRPC1 KO mice fed a HF diet and exercised had decreased expression of 
the autophagy marker MAP1LC3A and increased p62 expression along with an 
increase in apoptosis markers (particularly the ratio of Bax/Bcl-xl). This is in 
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agreement with our previous findings that silencing of TRPC1 decreased 
autophagy and increased cell death (Sukumaran et al., 2015). Loss of TRPC1 also 
decreased phosphorylation of ERK2, which is consistent with previous studies 
where activation of Ca2+ channels in adipocytes increased ERK2 phosphorylation 
(Ye et al., 2012). In addition, loss of TRPC1 decreased the number of larger 
adipocytes. These findings suggest that elimination of TRPC1-mediated Ca2+ entry 
in TRPC1 KO mice promotes suppression of autophagy in HF diet-fed and 
exercised mice resulting in increased adipocyte cell death. These results are 
consistent with previous studies where patients with metabolic syndrome also have 
higher serum Ca2+ levels (Saltevo et al., 2011; Sorva and Tilvis, 1990), which could 
be due to the loss of TRPC1 or other Ca2+ channels that mediate Ca2+ entry in 
adipocyte cells, thereby increasing serum Ca2+ levels. Interestingly, in skeletal 
muscle, even though contraction does not depend on extracellular Ca2+ (Armstrong 
et al., 1972), Ca2+ entry through TRPC1 is essential for maintaining force during 
sustained repeated contractions. TRPC1 KO mice experience muscle fatigue 
during endurance exercise though spontaneous wheel running activity is 
unchanged (Zanou et al., 2010). Our data is in agreement as we showed no 
alteration in voluntary exercise. However, a reduction in endurance exercise might 
be expected because loss of TRPC1 could impact mitochondrial respiration by 
altering Ca2+ homeostasis, due to an increase in total mitochondrial protein 
stimulated by exercise training (Holloszy, 1967; Scalzo et al., 2014), and Ca2+ is 
needed for proper functioning of mitochondria (Chan et al., 2009). In addition, ER 
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stress resulting from reduced Ca2+ entry could increase translocation of apoptotic 
factors into mitochondria thus permeabilizing the membrane, causing release of 
cytochrome c and activation of caspases, leading to mitochondrial-mediated cell 
death (Budihardjo et al., 1999; Pan et al., 2001; Selvaraj et al., 2009; Wei et al., 
2001). These findings demonstrate that loss of TRPC1 disrupts Ca2+ homeostasis 
potentially resulting in mitochondrial-mediated cell death of adipocytes. Although 
a previous study has shown that knockdown of TRPC1 only attenuated non-
stimulated Ca2+ influx in breast cancer cells (Davis et al., 2012), our results using 
adipocytes did not show any decrease in basal Ca2+ entry. These results suggest 
that while in breast cancer cells other Ca2+ influx channels (Orai1) might be more 
important for SOCE, TRPC1 is essential for adipocyte function, especially in 
blocking the effects of exercise in HF diet-induced obesity. The mechanism by 
which TRPC1 KO mice fed a HF diet and exercised are protected from obesity and 
type II diabetes risk needs further investigation. However, our study and another 
published study (Ye et al., 2012) indicate that loss of Ca2+ might be the main factor 
that inhibits the formation of metabolic syndrome.  
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CHAPTER V 
TRPC1 TRANSPORTS Ca2+ INVOLVED IN SNARE COMPLEX FORMATION 
DURING ADIPONECTIN SECRETION 
 
Introduction 
Adipose tissue was initially considered to be an inert fat storage depot until 
the discovery of linkages between obesity and inflammation. Currently, adipose 
tissue is considered a complex endocrine organ secreting over 600 bioactive 
factors (Lehr et al., 2012; MacDougald and Burant, 2007), termed adipokines. 
These adipokines influence diverse physiological processes by relaying 
information to other metabolically active organs such as muscle, liver, pancreas, 
and brain, thereby modulating systemic metabolism (Ouchi et al., 2011). 
Importantly, increased adipose accumulation, as seen in obesity, correlates to 
dysregulation of adipokine secretion (Arita et al., 1999; Matsuzawa, 2010; Maury 
and Brichard, 2010) and increases susceptibility to other diseases (Rasouli and 
Kern, 2008). Altering levels of the adipokines, mainly adiponectin (Fruebis et al., 
2001; Okada-Iwabu et al., 2013) and leptin (Stern et al., 2016), have shown to 
improve energy homeostasis and offset diet-induced obesity. Thus, adipokines 
have potential to be therapeutic targets to combat/counter or reduce obesity and 
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other metabolic diseases, however, a full understanding of the mechanisms and 
intracellular mediators that modulate adipokine secretion within adipose tissue is 
first required. 
Adiponectin is a cytokine primarily secreted from mature adipocytes, 
however it has been shown to be expressed in other tissues including human and 
murine osteoblasts, liver, myocytes, epithelial cells, and placental tissue (Achari 
and Jain, 2017). Adiponectin is known to have an anti-inflammatory effect as it 
inhibits the expression of vascular adhesion molecules, scavenger receptors, is an 
antagonist of toll like receptors (TLR) and their ligands, and pro-inflammatory 
cytokines TNFα, IL-6 and IL-1β in various tissues types (Fantuzzi, 2013; Tsatsanis 
et al., 2005; Turer and Scherer, 2012). Anti-oxidant properties have also been 
attributed to adiponectin which are mediated by the cyclic AMP/protein kinase A 
pathway (Ebrahimi-Mamaeghani et al., 2015; Scherer et al., 1995; Yamauchi and 
Kadowaki, 2013). Adiponectin has garnered interest as a metabolic therapeutic 
due to its positive effect on lipid and glucose metabolism in kidney, liver and 
muscle. Utilizing the AMPK pathway, adiponectin is known to increase fatty acid 
oxidation, mitochondria biogenesis, and insulin sensitivity (Achari and Jain, 2017; 
Komai et al., 2014).  
Adiponectin is one of the most abundant circulating cytokine accounting for 
roughly 0.01% of total serum protein (Villarreal-Molina and Antuna-Puente, 2012). 
Normal human serum adiponectin concentrations are 3 to 30 µg/mL (Ouchi et al., 
2003), however concentrations have been found to be negatively correlated to 
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obesity and positively correlated to insulin sensitivity (Achari and Jain, 2017; 
Kadowaki et al., 2006; Kovacova et al., 2012). Decreases in blood concentrations 
during obesity have been attributed to disturbances in both production and 
Figure 31 Adiponectin synthesis  
Schematic representation of the steps involved in the production and secretion of 
adiponectin. Monomeric adiponectin (mAd) is the initial form and post-
translationally modified and oligomerized into trimers (low molecular weight, 
LMW), hexamers (medium, MMW) and oligomeric (high, HMW) forms. Reprinted 
from “Adiponectin action: A combination of endocrine and autocrine/paracrine 
effects” K. Dadson, 2011, Frontiers in Endorcinology, 2011;2-62. Copyright 2011 
by Frontiers Media SA. Reprinted with permission. 
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secretion of adiponectin from adipose tissue (Hoffstedt et al., 2004; Kovacova et 
al., 2012; Liu and Liu, 2009). Interestingly, mice fed a high-fat diet and treated with 
a synthetic small-molecule adiponectin receptor (AdipoRon) agonist ameliorated 
insulin resistance and glucose intolerance (Okada-Iwabu et al., 2013). Moreover, 
treatment with this synthetic adiponectin inhibited the onset of diabetes in 
genetically obese rodent model db/db mice further highlighting the prospect of 
using adiponectin as a therapeutic target for metabolic disorders. 
Adiponectin is initially synthesized as a monomeric pre-hormone (Figure 
32), then oligomerized into three isoforms and packaged in vesicles until 
stimulated for release (Dadson et al., 2011). Expression is transcriptionally 
regulated by the transcription factors C/EBPs, sterol regulatory element binding 
protein 1c (SREBP1c), and nuclear receptor peroxisome proliferator-activated 
receptors γ (PPARγ) which is induced by the thiazolidinedione (TZD) family of 
drugs (Dadson et al., 2011; Liu and Liu, 2009; Yamauchi and Kadowaki, 2013). 
Adiponectin is first formed as a 30 kDa monomer that is assembled within the ER 
into complex isoforms such as high (HMW 300 kDa), medium (MMW 140 kDa), 
and low (LMW 67 kDa) molecular weights (Figure 32). The HMW isoform is thought 
to be the most biologically active and Ca2+ has been implicated as important for its 
formation (Banga et al., 2008; Rosen and Spiegelman, 2014). Interestingly, the 
ratio of plasma HMW adiponectin to total adiponectin appears to be a stronger 
indicator of insulin resistance than measuring total adiponectin levels alone due to 
its high correlation with glucose and insulin levels (Lara-Castro et al., 2006). 
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Release of adiponectin from adipocytes has been shown to be insulin and 
Ca2+ dependent (Bogan and Lodish, 1999; Cong et al., 2007; Komai et al., 2014; 
Xie et al., 2008) and a high-Ca2+ diet has been shown to stimulate the expression 
of adipokines along with inhibition of pro-inflammatory factors (Sun and Zemel, 
2007). The mechanism of secretion is mediated by golgi-localized, gamma adaptin 
ear-containing, ARF-binding protein 1 (GGA1)-coated vesicles originating at the 
Golgi with exocytosis being regulated through protein kinase A (PKA)-independent 
cAMP stimulation in both a Ca2+ dependent and independent process (Komai et 
al., 2014; Xie et al., 2008). Though Ca2+ dependency has been shown in 
adiponectin exocytosis, the specific Ca2+ channel involved has yet to be 
determined. We’ve shown in previous chapters the high expression and 
importance of TRPC1 in adipocyte function, thus TRPC1 could likely be involved 
in the Ca2+ dependent mode of adiponectin secretion (Baboota et al., 2014; Bishnoi 
et al., 2013; Sukumar et al., 2012).  
Regulated exocytosis in adipocytes mediates key functions, exemplified by 
insulin-stimulated secretion of peptides such as adiponectin and recycling of 
intracellular membranes containing GLUT4 glucose transporters to the cell surface 
(Bogan and Lodish, 1999). Plasma membrane synaptosomal-associated protein 
25 (SNAP-25) and syntaxin-1, termed t-SNAREs, and secretory vesicle-
associated protein 2 (VAMP-2 or v-SNARE), are part of the conserved protein 
complex involved in the fusion of opposing membranes necessary for exocytosis 
(Söllner et al., 1993; Trimble et al., 1988; Zhang et al., 2016) (Figure 33). An 
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important feature of each of these proteins is a stretch of heptad repeats, termed 
SNARE motifs, which serve as co-binding locations (Fasshauer et al., 1998; 
Weimbs et al., 1997). Syntaxin-1 and VAMP-2 each contain a single SNARE motif 
while SNAP-25 contains two. During the initial stage of exocytosis, the vesicle 
approaches the PM and VAMP-2, syntaxin-1, and SNAP25 interact with each other 
via SNARE motifs to form quaternary bundles of a-helices called SNARE 
complexes. It has been well demonstrated that Ca2+ provides the final event 
needed for vesicle fusion and release of its content, however channel specificity is 
still elusive (Di Giovanni et al., 2010; Südhof and Rothman, 2009). Our laboratory 
has shown an interaction between VAMP-2 and TRPC3 in neuronal and epithelial 
cells was necessary for exocytosis (Singh et al., 2004). Interestingly, there is data 
implying an interaction between SNAP-25 and TRPC1 in human platelets during 
TRPC1 trafficking (Redondo et al., 2004) which could suggest a more involved role 
for the two proteins in SNARE complex formation.  
As shown in Chapter 2, TRPC1-/- adipose tissue has reduce SOCE function 
and differentiation leading us to investigate whether other adipose functions are 
impaired. Ca2+ has been shown in numerous studies to be involved in the secretion 
of adipokines from adipose tissue (Komai et al., 2014; Sukumar et al., 2012; Ye et 
al., 2010), however the Ca2+ channel(s) involved have not been identified. The aim 
of this study was to identify the endogenous Ca2+ entry channel in adipocytes 
necessary for adipokine production and secretion. We report that loss of TRPC1 
function reduces serum adiponectin concentrations in TRPC1-/- mice due to 
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impaired exocytosis of adiponectin from adipocytes. We further show TRPC1-
mediated Ca2+ is necessary for SNARE complex formation necessary for 
adiponectin loaded vesicle fusion.  
  
Figure 32 SNARE complex formation 
Assembly of SNARE complex formation depicting the steps involved with vesicle 
fusion and exocytosis. (I) monomeric t-SNAREs SNAP-25 and syntaxin located 
on the PM, (II) partial assembly of t-SNARE complex, (III) the folded t-SNARE 
complex and introduction of vesicle associated proteins synaptotagamin and 
VAMP2 along with Munc-18, (IV) activated SNARE complex, (V) partially 
zippered trans-SNARE complex, (VI) introduction of Ca2+ completes the zippered 
SNARE complex and exocytosis occurs. Reprinted from “Single-molecule study 
of t-SNARE complex” by X. Zhang, 2016, Proceedings of the National Academy 
of Sciences, 113(50) E8031-E8040. Copyright 2016 by Proceedings of the 
National Academy of Science. Reprinted with permission. 
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Results 
 
Serum adipokines levels are reduced in TRPC1-/- mice 
To determine whether the reduction in Ca2+ influx in TRPC1-/- adipose tissue 
alters adipokine levels, we assessed serum adiponectin and leptin concentrations 
of WT and TRPC1-/- mice. Elisa assessed serum concentrations of both 
adiponectin and leptin were significantly reduced in TRPC1-/- mice as compared to 
their WT counterpart (Figure 34 A, B), whereas no change in food intake was 
observed (Figure 25). Adiponectin and leptin are almost entirely produced by 
adipocytes which led us to question whether the reduction in serum concentrations 
seen in TRPC1-/- mice was due to a decrease in overall production. To assess this, 
Figure 33 Serum adipokines are altered in TRPC1-/- mice. 
Elisa assessed total serum APN (A) and leptin (B) of WT and TRPC1-/- mice 
aged 3-9 months, APN n=6, leptin n=8. Graphs are mean ± SEM, 
significance: *, p < 0.05 
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Subc AT and VAT lysates from WT and TRPC1-/- mice were evaluated for 
adiponectin and leptin protein expression. No difference was observed in either 
adiponectin or leptin expression between adipose tissue obtained from TRPC1-/- 
or their WT counter parts indicating loss of serum concentrations is most likely not 
Figure 34 No difference in leptin and adiponectin concentrations within 
adipose tissue 
Western blot and quantification of leptin and adiponectin protein expression 
normalized to actin of WT and TRPC1-/- tissue lysates of Subc AT and VAT and 
quantified. 
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due to a malfunction in production (Figure 35). Interestingly, both WT and TRPC1-
/- VAT samples contained higher levels of both adiponectin and leptin than Subc 
AT samples possibly indicating VAT may play a larger role as a distributor of 
adipokines. These results suggest that reduced serum adiponectin and leptin 
concentrations in TRPC1-/- mice are not likely a consequence of lower adipose 
tissue production.  
 
Exercise recovers diminished serum  
adiponectin concentrations in TRPC1-/- mice 
Exercise is known to increase circulating adiponectin concentrations 
(Kriketos et al., 2004; Lee et al., 2011; Wang et al., 2015), however there are 
conflicting views on the effect of a high-fat diet on serum adiponectin 
concentrations (Barnea et al., 2006; Bullen et al., 2007). This lead us to investigate 
whether a high-fat diet and exercise would alter serum adipokine concentrations 
in TRPC1-/- mice. WT and TRPC1-/- mice were placed on a diet of either normal-
chow (16% fat) or high-fat (45% fat) diet for 12 weeks and subjected to voluntary 
wheel running exercise. At the end of the 12 weeks, serum adiponectin 
concentrations were assessed. Within WT groups, adiponectin concentrations 
were increased in sedentary WT mice fed a high-fat diet and in exercised WT mice 
fed a normal-chow diet as compared to WT sedentary mice fed a high-fat diet, 
however, the combination of high-fat diet and exercise had no effect on adiponectin 
concentrations (Figure 36).  Similar to Figure 34, sedentary TRPC1-/- mice feed a 
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normal-chow diet had significantly reduced adiponectin concentrations as 
compared to their WT counterparts which was replicated in sedentary TRPC1-/- 
mice feed a high-fat diet indicating the increase in adiponectin due to high-fat diet 
is impaired in TRPC1-/- mice. Notably, reduced adiponectin concentrations in 
TRPC1-/- mice fed either normal-chow diet or high-fat diet was offset by the addition 
Figure 35 Reduced serum adiponectin concentrations in TRPC1-/- mice 
recovered when exercised  
Total serum adiponectin from WT and TRPC1-/- mice fasted overnight after 12 
weeks on normal-chow (16% fat) or high-fat (45% fat), n=8 mice. Normal-chow 
(NF), High-fat (HF). Significant (p < 0.05) effects from 3-way ANOVA are 
indicated by + (mouse type), × (diet), and # (exercise). Graphs are mean ± SEM, 
significance: *, p < 0.05; **, p < 0.01.; ***, p < 0.001. 
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Figure 36 Serum adiponectin isoforms altered in TRPC1-/- mice 
Serum adiponectin isoforms (A) assessed by non-denaturing PAGE. Optical 
density of each isoform (HMW (high molecular weight), MMW (middle 
molecular weight), LMW (low molecular weight)) normalized to total protein 
from respective Ponceau S stains and quantified (B). (C) Non-denaturing 
PAGE of Subc AT and VAT protein tissue lysates and quantified. Graphs are 
mean ± SEM, significance: *, p < 0.05; **, p < 0.01. 
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of exercise. Overall this indicates that serum adiponectin concentrations in TRPC1-
/- mice are affected by the addition of exercise, but a high-fat diet results in no 
change. 
 
Adiponectin isoforms are altered in TRPC1-/- mice 
The isoform composition of total serum adiponectin has been shown to be 
important to overall health assessment due to its correlation with glucose and 
insulin levels (Lara-Castro et al., 2006), thus we assessed the composition of 
serum samples from Figure 34. Evaluation of serum adiponectin from WT and 
TRPC1-/- mice by non-denaturing gel electrophoresis indicated a significant 
reduction in both HMW and MMW isoforms with no difference in LMW (Figure 37 
A, B). To understand whether the reduction of HMW and MMW isoforms in TRPC1-
/- mouse serum is due to an issue in adiponectin production and folding within 
adipose tissue, Subc AT and VAT adiponectin isoform composition was assessed. 
In all three isoforms, there was no difference observed between WT and TRPC1-/- 
in either Subc AT or VAT indicating isoform assembly is not a likely candidate for 
differences in serum levels (Figure 37 C). Within these studies, we observed 
TRPC1-/- mouse serum contains significantly less of the biologically active form of 
adiponectin (HMW) than WT mice, which does not correspond to intracellular 
tissue quantities. 
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Diminished adiponectin secretion in Subc AT from TRPC1-/- mice  
Secretion of adiponectin from adipose tissue can be triggered by insulin 
(Bogan and Lodish, 1999; Cong et al., 2007). To mimic this process ex vivo, fresh 
Subc AT and VAT from WT and TRPC1-/- mice was cut into 8-15 mg pieces, 
suspended in media, and stimulated with insulin (100 nM) for 6 hours. The media 
was then examined via ELISA and normalized to mg of tissue to determine total 
adiponectin concentrations. Upon insulin stimulation, secreted adiponectin 
concentrations from WT Subc AT were significantly increased compared to non-
treated control (Figure 38 A). Importantly, treatment of TRPC1-/- Subc AT with 
Figure 37 Insulin stimulated secretion diminished in TRPC1-/- Subc AT 
Elisa assessed adiponectin secreted from Subc AT (A) and VAT (B) samples 
in 8-15 mg pieces from WT and TRPC1-/- stimulated with insulin (100 nM) for 
6 hours, n=9. Concentration of adiponectin normalized to tissue size (mg). 
Graphs are mean ± SEM, significance: *, p < 0.05. 
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insulin did not result in a significant increase in adiponectin secretion as seen in 
the WT Subc AT, but was significantly lower that WT Subc AT stimulated with 
insulin (Figure 38 A). Interestingly, insulin stimulation of VAT from both WT and 
TRPC1-/- mice did not result in a significant increase in adiponectin secretion 
(Figure 38 B), however all VAT samples secreted roughly 2-fold more adiponectin 
than Subc AT samples. This could be attributed to the increased endogenous 
levels seen in VAT (Figure 35) and possibly indicate non-stimulated secretion from 
VAT is higher than Subc AT. 
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Figure 38 Distribution of adiponectin isoforms from secretion samples 
Analysis of adiponectin isoforms from Figure 37 assessed by non-denaturing 
PAGE. Optical density of each isoform (HMW (high molecular weight), MMW 
(middle molecular weight), LMW (low molecular weight)) is shown as a 
percentage of total adiponectin for each lane. No significance was 
determined for all samples. 
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 Analysis of adiponectin isoforms upon insulin stimulation showed a slight 
increase in MMW secretion in Subc AT from both WT and TRPC1-/-, however no 
significance was determined. Overall the distribution of adiponectin isoforms was 
similar in all tissue types and animals (Figure 38). This data indicates adipocytes 
with TRPC1 deficiency have a reduced response to insulin–stimulated secretion 
of adiponectin, but it does not affect the overall distribution of isoforms secreted. 
 
Reduced SNARE protein interactions in TRPC1-/- adipose tissue 
Our lab has shown that a functional interaction between SNARE family 
proteins and Ca2+ influx is required for intracellular vesicle fusion (Singh et al., 
2004), thus we investigated whether impairment of adiponectin secretion may be 
due to diminished SNARE interactions due to TRPC1 loss. VAMP-2 is found within 
the plasma membrane of intracellular vesicles and is involved in the docking of the 
vesicles to the plasma membrane by interacting with plasma membrane SNARE 
proteins, such as syntaxin-1 and SNAP 25. To assess whether TRPC1 may be 
involved in SNARE complex formation needed to exocytose adipokine vesicles 
from adipose tissue, co-immunoprecipitation was performed on fresh adipose 
samples. Subc AT and VAT were isolated from WT and TRPC1-/- mice, 
homogenized, quantified, and incubated with insulin (100 nM), SKF (10 mM), or 
Tg (1 mM) for 30 min. In this model, insulin treatment mimics the initial stages of 
adiponectin secretion (as seen in Figure 38) and SKF treatment was used to 
determine whether blocking store-mediated Ca2+ influx channels would reduce 
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insulin-induced SNARE interactions. As shown in Figure 40, plasma membrane 
SNARE components syntaxin-1 and SNAP-25 co-immunoprecipitated with 
VAMP2 in both WT and TRPC1-/- control samples. Upon treatment with insulin, the 
interaction of VAMP-2 with syntaxin-1 and SNAP-25 increased in WT samples, 
however no change was observed in TRPC1-/- samples. Pretreatment with SKF 
prior to insulin did not alter interactions of SNAP-25 with VAMP-2 in WT adipose 
tissue, however it did reduce interactions of VAMP-2 with syntaxin-1. Treatment of 
TRPC1-/- adipose tissue cells with SKF had no effect on interactions of either 
syntaxin-1 or SNAP-25 with VAMP-2. Raising [Ca2+]i and initiating SOCE through 
treatment with Tg increased SNAP-25 and VAMP-2 interactions in WT adipose 
tissue, however it did not result in a change in WT VAMP-2 and syntaxin-1 
interactions. Further, no variation in interactions between VAMP-2 and SNAP-25 
or syntaxin-1 was observed upon treatment with Tg within TRPC1-/- adipose tissue 
indicating depletion of the ER and initiation of SOCE mechanisms is not enough 
to overcome the loss of TRPC1. Together these results indicate insulin stimulated 
SNARE complex formation in adipose tissue involves TRPC1-mediated Ca2+ entry, 
which is needed for exocytosis of adiponectin. 
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Figure 39 Reduced SNARE protein interactions in TRPC1-/- adipose tissue 
Co-immunoprecipitation assay of SNARE complex proteins in combined Subc 
AT and VAT tissue lysates from WT and TRPC1-/- upon stimulation with insulin 
(100 nM), SKF (20 μM), or Tg (2 μM). Western blot analysis was performed using 
anti-Vamp2 antibody and immunoprecipitating with anti-SNAP25 (A,C) and anti-
Syntaxin-1 (B,D) antibodies. Graphs are mean ± SEM, significance: *, p < 0.05; 
**, p < 0.01. 
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Conclusion 
 
Reduced secretion of adiponectin resulting in low serum concentrations is 
a common feature of obesity (Kovacova et al., 2012), whereas low serum leptin 
can be used as an indicator of malnutrition (Amirkalali et al., 2010). TRPC1-/- mice 
present both reduced serum adiponectin and leptin concentrations, however 
TRPC1-/- mice do not display either of these phenotypes. Food consumption and 
weight measurements of TRPC1-/- mice were similar to WT throughout their lifetime 
(Figure 25), however as we saw previously (Figure 21), as TRPC1-/- mice age, their 
volume of adipose deposits increases. This increase in adiposity later in life is 
could be attributed to decreased differentiation as discussed in Chapter III or to 
suppressed adiponectin secretion which lowers overall body metabolism. 
Importantly, equal concentrations of adiponectin and leptin were observed within 
the Subc AT and VAT samples of WT and TRPC1-/- mice, which is contrary to the 
reduced serum concentrations in TRPC1-/- mice (Figure 35). This indicates that 
there is no reduction in adipokine production, but rather the release of adipokines 
is affected in TRPC1-/- mice.  
When challenging both WT and TRPC1-/- mice with a high-fat diet and 
exercise for 12 weeks, we observed an increase in total serum adiponectin 
concentrations in sedentary WT mice feed a high-fat diet and exercised WT mice 
on a normal-chow. It has been well established that exercise increases circulating 
adiponectin concentrations (Kriketos et al., 2004; Lee et al., 2011; Wang et al., 
2015), however the effect of a high-fat diet on serum adiponectin is still debated. 
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Differing studies have shown both increases and decreases in serum adiponectin 
concentrations when mice are fed a high-fat diet (Barnea et al., 2006; Bullen et al., 
2007; Chaolu et al., 2011) and may be reflective of acute versus long-term feeding. 
This discrepancy in results after high-fat feeding may explain why WT mice feed a 
high-fat diet and exercised did not display an increase in adiponectin 
concentrations as compared to sedentary WT mice on a normal-chow diet. 
Importantly, the results of the 12 week study confirmed our previous result that 
sedentary TRPC1-/- mice on a normal-chow diet have significantly decreased 
serum adiponectin concentrations and as we saw in Figure 24,  sedentary TRPC1-
/- mice fed normal-chow did not display a difference in overall body weight or fat 
mass as compared to WT. This indicates reduced serum adiponectin 
concentrations in TRPC1-/- mice is not a result of increased adiposity further 
indicating a dysfunction in adiponectin secretion. It is also notable that the high-fat 
diet had no effect on sedentary TRPC1-/- mice, however the addition of exercise 
did result in differences in both TRPC1-/- mice feed a high-fat and normal-chow 
diet.  
Exercise is thought to increase circulating adiponectin concentrations 
through a multitude of processes including increased expression of adiponectin 
receptors in muscle (Tsuchida et al., 2004; Zeng et al., 2007), increased secretion 
of adiponectin from muscle through PPARy activation (Amin et al., 2010), and 
release of adiponectin from adipose tissue due to exercise induced fat mass loss 
(Wang et al., 2015). The theory that increased serum adiponectin is due to release 
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of adiponectin stores from exercise induced fat mass loss is most likely not 
occurring in our study as the only animal that had reduced weight and fat mass 
was TRPC1-/- mice that were fed a high-fat diet and exercised (Figure 24). If this 
theory was correct, we would expect the increased serum adiponectin 
concentrations in exercised WT mice on normal-chow to be correlated to a 
decrease in fat mass, which was not seen. The more probable explanation would 
be increases in either adiponectin receptors or secretion from muscle, which could 
compensate for the reduced adiponectin secretion from adipose tissue due to 
TRPC1 loss. 
Interestingly, it has been found that the greatest reduction in serum 
adiponectin in obese subjects is from Subc AT and the metabolically active isoform 
HMW (Kovacova et al., 2012). Analysis of serum adiponectin isoforms in our study 
indicates a similar reduction in HMW with the addition of MMW, however internal 
adipose tissue concentrations of adiponectin were similar between WT and 
TRPC1-/-. This reduction in TRPC1-/- serum HMW isoform is most likely due to 
increased utilization by downstream targets, such as muscle and liver, since 
overall abundance is diminished. However, due to the lack of understanding of the 
purpose and distribution of adiponectin isoforms, more investigation is needed. 
The dependence on Ca2+ for the secretion of adipokines has been shown in 
numerous studies (Bogan and Lodish, 1999; El Hachmane et al., 2018; Komai et 
al., 2014; Levy et al., 2000; Sukumar et al., 2012; Ye et al., 2010), however the 
Ca2+ channel(s) involved have not been identified. The most extensive work has 
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shown that cAMP stimulates exocytosis of adiponectin-containing vesicles in a 
Ca2+ dependent and independent manner (Komai et al., 2014), but no channel 
specificity was determined. Within the study by Sukumar et al., alterations in 
adiponectin secretion due to blockage of TRPC1 and TRPC5 in differentiated 3T3-
L1 adipose cells through use of antibodies and siRNA was investigated. Contrary 
to our findings, their results showed an increase in adiponectin in the extracellular 
media indicating increased secretion, however no measurement of changes in 
internal adiponectin production, basal internal concentrations, or agonist mediated 
release were determined. Also, the 3T3-L1 cell line originates from a single clone, 
resulting in a cell line incomparable to the characteristics of primary cell culture 
models (Ruiz-Ojeda et al., 2016). Because of this, we do not feel the 3T3-L1 cell 
line is a precise model of the in vivo state, thus we believe our usage of primary 
cell lines from SVF and ex vivo tissue stimulation is a more accurate 
representation. 
It has been well documented that regulated exocytotic events including the 
fusion of intracellular organelles such as synaptic vesicles, secretory 
vesicles/granules, or lysosomes with the plasma membrane are Ca2+-dependent 
(Reddy et al., 2001; Royle and Murrell-Lagnado, 2003). In particular, TRPC 
channels have been implicated in the GPR40 signaling pathway of glucose-
stimulated insulin secretion in pancreatic beta-cell (Yamada et al., 2016). Within 
secretory pathways, it has been suggested that increases in [Ca2+]i is needed in 
the vicinity of organelles (Barclay et al., 2005; Burgoyne and Clague, 2003), thus 
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our lab began investigation into the recruitment of Ca2+ channels to the site of 
fusion. Our lab previously demonstrated a functionally significant interaction 
between TRPC3 and SNARE proteins involved in intracellular vesicles fusion 
(Singh et al., 2004). Within this study, TRPC3 was observed to colocalize and co-
immunoprecipitate with VAMP-2 in neuronal cells, thus we theorized that this 
phenomenon may not be isolated to TRPC3. Utilizing this theory, we investigated 
whether TRPC1 may be important for SNARE complex formation adipocytes. To 
understand the mechanisms as to how TRPC1 regulates adipokine secretion, we 
stimulated fresh homogenized WT and TRPC1-/- adipose tissue with various 
agents and measured the interactions of VAMP-2 with SNAP-25 and syntaxin-1. 
Insulin stimulation induced the secretion of adiponectin and increased interactions 
of VAMP-2 with both SNAP-25 and syntaxin-1 in WT adipose tissue indicating a 
possible mechanistic action for adiponectin secretion. Treatment of adipocytes 
with Tg has shown both an increase and a decrease in adiponectin secretion in a 
time dependent manner (Torre-Villalvazo et al., 2018), thus we explored whether 
short term treatment with Tg would alter SNARE interactions. As seen in Figure 
40, a 30 min treatment with Tg increased VAMP-2 and SNAP-25 interactions only 
in WT adipose tissue. Interestingly, neither insulin or Tg resulted in changes in 
VAMP-2 interactions with either SNAP-25 and syntaxin-1 within TRPC1-/- adipose 
tissue which indicates a role for TRPC1 in insulin stimulated vesicle fusion. We 
believe these results provide enough evidence to state that insulin stimulated 
TRPC1 mediated Ca2+ influx is involved in fusion of VAMP-2 with SNAP25 and 
114 
 
syntaxin1, thus necessary for proper secretion of adipokines. Overall, our results 
provide evidence that TRPC1 not only plays a key role in adipocytes differentiation, 
but is essential for adipokine secretion, and dysfunction in these vital processes 
could lead to obesity and metabolic syndrome. 
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CHAPTER VI 
LOSS OF TRPC1 IS LIKELY NOT THE CAUSE OF 
REDUCED ADIPONECTIN SIGNALING IN SKELETAL MUSCLE 
 
Introduction 
 As discussed in Chapter V, adiponectin is known to regulate lipid 
metabolism and mitochondrial biogenesis in a number of target organs including 
muscle and liver (Achari and Jain, 2017). The effects of adiponectin are mediated 
in these tissues primarily via the action of two plasma membrane bound atypical 
seven-transmembrane domain receptors, named AdipoR1 and AdipoR2 
(Yamauchi et al., 2003) (Figure 41). Both receptors contain an intracellular N-
termini and extracellular C-termini and are significantly homologous with 67% 
amino acid identity (Kadowaki et al., 2006). AdipoR1 is ubiquitously expressed with 
the highest abundance in skeletal muscle, while AdipoR2 is predominantly 
expressed in the liver (Wang et al., 2009; Yamauchi and Kadowaki, 2013). 
Differences between AdipoR1 and AdipoR2 have been identified in binding 
properties (Yamauchi et al., 2003), cell surface  expression (Heiker et al., 2010; 
Keshvari et al., 2017), and temporal signaling profiles (Keshvari and Whitehead, 
2015). Interestingly, a deficiency in AdipoR1, AdipoR2, or both receptors produced
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Figure 40 Adiponectin signaling through AdipoR1 and AdipoR2 
Adiponectin has three known receptors of AdipoR1, AdipoR2, and T-cadherin (T-cad). 
AdipoR1/2 can interact with adaptor protein containing pleckstrin homology domain, 
phosphotyrosine-binding domain, and leucine zipper motif (APPL1). AdipoR1 increases 
Ca2+ influx to activate Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) and 
subsequent downstream kinases. Ca2+/calmodulin-dependent protein kinase (CaMK) and 
AMP-activated protein kinase (AMPK) can increase peroxisome proliferator-activated 
receptor (PPAR) gamma coactivator 1 alpha (PGC-1α) mRNA expression thereby 
increasing mitochondrial biogenesis and fatty acid oxidation. AdipoR1 activates liver kinase 
B1 (LKB1) and AMPK. AdipoR2 is predominantly expressed in the liver and can activate 
PPARα to increase FA oxidation and insulin sensitivity. Reprinted from “The multifaceted 
and controversial immunometabolic actions of adiponectin” by S. Esmaili, 2014, Trends in 
Endocrinology and Metabolism, 25(9), 444-451. Copyright 2014 by Elsevier. Reprinted with 
permission. 
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glucose intolerance in a diet-induced obesity mouse model (Yamauchi et al., 
2007), while muscle-specific AdipoR1-KO mice also display metabolic dysfunction 
(Iwabu et al., 2010). Overexpression of AdipoR1 in rat skeletal muscle has been 
shown to improve insulin resistance and promote glucose uptake (Patel et al., 
2012). Recently, overexpression of AdipoR1 or AdipoR2 in mouse tibialis anterior 
muscle increased adiponectin signaling, however the effects were diminished in 
obese mice despite no reduction in circulating adiponectin levels (Keshvari et al., 
2017). The overexpression of AdipoR1 or AdipoR2 had no effect on circulating 
adiponectin concentrations, however, knockouts of the receptors had differing 
phenotypes. Mice deficient of AdipoR1 had increased fat mass, decreased glucose 
tolerance, and no change in plasma adiponectin concentrations while AdipoR2 
deficient mice were lean, had improved glucose tolerance, and increased plasma 
adiponectin concentrations (Bjursell et al., 2007). Much is still to be understood 
about adiponectin signaling, but evidence suggests the receptors AdipoR1 and 
AdipoR2 may play differing roles.    
Another adiponectin-binding partner is T-cadherin which has been identified 
in C2C12 myoblasts and skeletal muscle. Though T-cadherin has a high binding 
affinity for hexameric and HMW forms (Hug et al., 2004), it is not thought to have 
the same receptor properties as AdipoR1 and AdipoR2 as T-cadherin does not 
contain an intracellular domain. Interestingly, deficiency of T-cadherin in mice 
leads to a major upregulation of circulating adiponectin levels indicating some sort 
of role in adiponectin signaling (Williams et al., 2012). 
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 Bound to both AdipoR1 and AdipoR2 is adaptor protein containing 
pleckstrin homology domain, phosphor-tyrosine domain, and leucine zipper 
domain 1 (APPL1) which is known to positively modulate adiponectin signaling 
(Figure 41). Specifically, suppression of APPL1 reduces adiponectin signaling 
while overexpression increases downstream events (Cheng et al., 2007; Mao et 
al., 2006). The downstream targets of AdipoR1 and AdipoR2 are contrasting and 
result in different outcomes. AdipoR1, through APPL1, is known to promote AMP-
activated protein kinase (AMPK) activation and a subsequent increase in 
expression of master regulator peroxisome proliferator-activated receptor γ 
coactivator-1α (PGC-1α), whereas AdipoR2 mediates activation of peroxisome 
proliferator-activated receptor alpha (PPARα), both of which are involved in fatty 
acid oxidation (Jäger et al., 2007; Yamauchi et al., 2007). Another interesting 
difference between AdipoR1 and AdipoR2, is the involvement in Ca2+ influx in 
AdipoR1 signaling. Iwabu et al., 2010 showed that adiponectin binding to AdipoR1 
induces a Ca2+ influx, which activates Ca2+/calmodulin-dependent protein kinase 
kinase β (CaMKKβ) and subsequent AMPK. Within this study, downregulation of 
AdipoR1 by siRNA reduced the influx of Ca2+ and chelating Ca2+ with EGTA 
reduced phosphorylation of AMPK. Though there is strong evidence to suggest 
that Ca2+ is a component of the adiponectin signaling pathway, no work has been 
done to determine the channel responsible for its influx. 
 It has been demonstrated that SOCE partially contributes to the Ca2+ supply 
necessary for the maintenance of skeletal muscle contraction, however it has been 
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determined that it is not required for the initiation of muscle contraction (Cho et al., 
2017; Stiber et al., 2008). In skeletal muscle, SOCE is modulated much faster than 
non-excitable cells with activation occurring within a second whereas non-
excitable cells require tens of seconds (Nakipova et al., 2017). The fast kinetics of 
skeletal muscle SOCE is likely due to the pre-coupling of STIM1 to ORAI1 
(Dirksen, 2009; Stiber et al., 2008). Very little has been investigated regarding 
TRPC1 involvement in SOCE within skeletal muscle, but TRPCs have been shown 
to have important roles in skeletal muscle in other ways. In particular, TRPC1 has 
been shown to be important for skeletal muscle migration and differentiation (Louis 
et al., 2008; Zanou et al., 2012). Further, skeletal muscles from TRPC1−/− mice 
display smaller myofibre cross-sectional areas resulting in reduced contractional 
force over time (Zanou et al., 2010).  
 Within this study, we investigate the involvement of TRPC1 in adiponectin 
signaling pathway in muscle to determine whether loss of TRPC1 has an effect on 
downstream targets and upstream adiponectin serum concentrations due to failed 
signaling. We report that SOCE mechanisms are exhibited in both C2C12 muscle 
cell line and primary Extensor Digitorum Longus (EDL) muscle. Additionally, 
activation of AdipoR1 with the agonist AdipoRon results in an influx of Ca2+ which 
can be blocked by SKF and 2APB, however this blockage has no effect on the 
downstream targets of AMPK and PGC1α. Further, loss of TRPC1 in EDL muscle 
does not reduce the influx of Ca2+ due to AdipoRon treatment or PGC1α 
expression, however it does reduce the phosphorylation of AMPK. Together this 
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data indicates TRPC1 is most likely not a target channel for adiponectin signaling 
and loss TRPC1 does not affect downstream effects. 
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Results 
 
 Reduced expression of adiponectin targets in TRPC1-/- muscle 
Our first step was to determine whether reduced serum adiponectin 
concentrations in TRPC1-/- mice had an effect on the expression of genes targeted 
by adiponectin in liver and muscle. These included PGC1α, lipid metabolism genes 
of medium-chain acyl-CoA dehydrogenase (ACADM), fatty acid synthase (FASN), 
and acetyl-CoA carboxylase (ACC) along with mitochondrial biogenesis genes 
nuclear-encoded NRF1 (nuclear respiratory factor 1), mitochondrial transcription 
factor A (TFAM), and estrogen-related receptor alpha (ERRα). Interestingly, the 
two tissue types had differing expression levels even though they are both 
adiponectin targets (Figure 42). Liver showed no change in PGC1α or 
mitochondrial biogenesis genes, however TRPC1-/- mice had a significant increase 
in the lipid metabolism genes FASN and ACC as compared to WT mice. 
Conversely, muscle expression levels of TRPC1-/- mice were decreased in PGC1α, 
lipid metabolism ACC and FASN mRNA, and mitochondrial biogenesis NRF1 and  
ERRα. The muscle mRNA profile is similar to those reported due to decreases in 
serum adiponectin concentrations (Civitarese et al., 2006), however more 
investigation is needed to confirm.  
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Figure 41 mRNA expression of lipid metabolism and mitochondrial 
biogenesis genes in liver and muscle 
 
Isolated mRNA from liver and bicep femoris muscle of WT and TRPC1-/- mice 
were measured for the expression of peroxisome proliferator-activated receptor 
γ coactivator 1α (PGC1α), lipid metabolism genes of medium-chain acyl-CoA 
dehydrogenase (ACADM), fatty acid synthase (FASN), and acetyl-CoA 
carboxylase (ACC) along with mitochondrial biogenesis genes nuclear-encoded 
NRF1 (nuclear respiratory factor 1), mitochondrial transcription factor A (TFAM), 
and estrogen-related receptor alpha (ERRα), n= 3. Graphs are mean ± SEM, 
significance: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. 
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Differentiated muscle cell line exhibits SOCE characteristics 
Since muscle mRNA was reduced in TRPC1-/- mice, we investigated 
whether this was a result of reduced adiponectin signaling in muscle due to a lack 
of TRPC1 mediated Ca2+ influx. Before analyzing TRPC1 directly we first utilized 
the C2C12 muscle cell line and differentiated the cells into mature myotubes and 
measured Ca2+ influx and protein expression of SOCE proteins. Calcium imaging 
results indicated a reduction in [Ca2+]i peak upon treatment of Tg (release of ER 
stores) when cells were treated with either (10 uM) SKF or (100 uM) 2-
Aminoethoxydiphenyl borate (2-APB, an inhibitor of IP3 receptors and TRP 
Figure 42 C2C12 myotubes exhibit SOCE properties 
Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM 
Ca2+ to differentiated C2C12 myotubes treated with either 10 uM SKF or 100 uM 
2APB. Protein expression of SOCE proteins Stim1, TRPC1, and ORAI1 and 
adiponectin receptors AdipoR1 and AdipoR2 in C2C12 myoblasts and myotubes. 
Graphs are mean ± SEM, significance: **, p < 0.01; ***, p < 0.001. 
 
125 
 
channels) (Figure 43). Upon the addition of 1 mM extracellular Ca2+, a reduction in 
Ca2+ influx was observed in both SKF and 2APB treatments. This data confirms 
earlier reports that SOCE is displayed within C2C12 myotubes (Stiber et al., 2008), 
however, the administration of SKF and 2APB adversely affect ER store release. 
To confirm the presence of SOCE in C2C12 myotubes, protein expression of 
SOCE channels including STIM1, TRPC1, and ORAI1 was measured. Expression 
of all three SOCE proteins was highly evident in differentiated C2C12 myotubes, 
however expression of STIM1 and TRPC1 was minimal in undifferentiated C2C12 
myoblasts (Figure 43). Together this data indicates mature C2C12 myotubes 
exhibit SOCE characteristics and the STIM1, ORAI1, and TRPC1 complex may be 
involved. 
 
Blockage of SOCE reduces AdipoRon Ca2+ influx, 
but not downstream targets 
 To test whether SOCE was involved in adiponectin signaling pathway in 
muscle, we first confirmed the expression of the adiponectin receptors AdipoR1 
and AdipoR2 in C2C12 cells. As shown, neither receptor is expressed in C2C12 
myoblasts and only the AdipoR1 receptor is expressed in mature C2C12 myotubes 
(Figure 43). Utilizing the synthetic adiponectin receptor agonist AdipoRon, we 
measured the Ca2+ influx when SOCE channels are blocked. Administration of (50 
uM) AdipoRon resulted in an immediate influx of Ca2+ in C2C12 myotubes which  
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Figure 43 Blockage of SOCE reduces AdipoRon Ca2+ influx, but not 
downstream targets in C2C12 myotubes 
(A) Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 50 uM 
AdipoRon to differentiated C2C12 myotubes treated with either 10 uM SKF or 
100 uM 2APB in a Ca2+ buffer. (B) Western blot quantification of ratio of p-
AMPK to AMPK after 5 min treatment with 50 uM AdipoRon with representative 
blot in (D) n=7-13. (C) Relative mRNA expression of PGC1α after 90 min 
treatment with 50 uM AdipoRon quantified by RT-PCR, n=6. Graphs are mean 
± SEM, significance: *, p < 0.05, **, p < 0.01; ***, p < 0.001 
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was completely diminished with treatment of (10 uM) SKF or (100 uM) 2APB 
(Figure 44 A). We next tested whether this reduction in Ca2+ influx due to SKF and 
2APB would alter the downstream signaling targets of AdipoR1 of AMPK and 
PGC1α. C2C12 cells were pretreated with (10 uM) SKF and (100 uM) 2APB for 10 
min and then treated with (50 uM) AdipoRon for an additional 5 min and activating 
phosphorylation of AMPK was measured (Figure 44 B, D). As shown, AdipoRon 
induced a significant increase in AMPK phosphorylation, however treatment with 
SKF or 2APB had no effect. AdipoRon is known to induce increased expression of 
PGC1α mRNA after 90 min (Okada-Iwabu et al., 2013), thus we quantified PGC1α 
mRNA expression after pretreatment with (10 uM) SKF and (100 uM) 2APB for 10 
min. Results are inconclusive as treatment with SKF and 2APB on PGC1α mRNA 
is neither significantly increased from control or decreased from AdipoRon 
treatment (Figure 44). Overall, these data suggest that adiponectin receptor 
activation results in SOCE like Ca2+ influx, however blockage of SOCE is not 
detrimental to the progression of the signaling cascade. 
 
SOCE not diminished in primary muscle due to loss of TRPC1  
Even though the downstream targets of AdipoR1 were not affected by 
blockage of SOCE in C2C12 myotubes, we were still interested in whether TRPC1 
may be involved in adiponectin signaling in either a SOCE or SOCE independent 
manner. First, WT EDL muscle fibers were isolated and individually cultured to 
activate muscle satellite cells. Upon confluence, EDL myoblasts will naturally 
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differentiate into myotubes with twitching observed around day 7. We first 
established whether primary WT EDL muscle cultures exhibit the same SOCE 
mechanisms as C2C12 cells by blocking SOCE channels with SKF or 2APB. As 
seen in Figure 45 A, WT EDL efflux relatively the same from ER stores upon 
treatment with Tg, however treatment with either (10 uM) SKF or (100 uM) 2APB 
reduced the influx of Ca2+ upon addition of 1 mM Ca2+. We next tested TRPC1-/- 
Figure 44 WT EDL muscle exhibits SOCE mediated Ca2+ influx which is 
not diminished by loss of TRPC1 
EDL muscle was isolated from WT and TRPC1-/-, cultured, and differentiated 
into mature EDL myotubes as described in Methods. (A) Quantification of Fura-
2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM Ca2+ to WT EDL 
myotubes treated with either 10 uM SKF or 100 uM 2APB. (B) Quantification 
of Fura-2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM Ca2+ to WT 
and TRPC1-/- EDL myotubes treated with either 10 uM SKF or 100 uM 2APB. 
Graphs are mean ± SEM, significance: **, p < 0.01. 
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EDL in the same manner. As compared to WT EDL, TRPC1-/- displayed no 
significant change in either ER store efflux due to Tg or Ca2+ influx due to addition 
of 1 mM Ca2+ to the extracellular solution (Figure 45 B). Together this indicates 
that EDL muscle do exhibit SOCE mechanisms, however loss of TRPC1 does not 
affect it.  
 
Initial influx of Ca2+ due to treatment with AdipoRon 
is not TRPC1 dependent 
 To determine the involvement of TRPC1 in adiponectin signaling, we first 
confirmed the expression of AdipoR1 in both WT and TRPC1-/- EDL. Neither WT 
or TRPC1-/- EDL express AdipoR2 and no difference of AdipoR1 expression was 
observed between WT and TRPC1-/- EDL (Figure 46, B). The next step was to 
measure the response of WT EDL to AdipoRon when SOCE mechanisms are 
blocked. AdipoRon administration resulted in a significant increase in Ca2+ influx 
which was blocked when treated with (10 uM) SKF or (100 uM) 2APB (Figure 46 
A). Comparison of Ca2+ influx upon treatment of AdipoRon resulted in no significant 
difference between WT and TRPC1-/- EDL (Figure 46 C). So far, this data indicates 
that treatment with the adiponectin receptor AdipoRon does not initiate a Ca2+ 
influx via TRPC1.  
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Loss of TRPC1 in EDL impairs the ability of AdipoRon to initiate 
downstream targets of adiponectin signaling 
The final step to determine involvement of TRPC1 in adiponectin signaling 
was to monitor the effects of AdipoRon on downstream targets of AMPK and 
PGC1α	in TRPC1-/- EDL. Addition of AdipoRon to WT EDL resulted in a more than 
2 fold increase in phosphorylation of AMPK after 5 minutes (Figure 47 A, B). When 
the same treatment was applied to TRPC1-/- EDL, there was a slight increase in 
Figure 45 AdipoRon initiated Ca2+ influx is not TRPC1 dependent 
(A) Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 50 uM 
AdipoRon to differentiated WT EDL myotubes treated with either 10 uM SKF or 
100 uM 2APB in a Ca2+ buffer. (B) Protein expression of AdipoR1 and AdipoR2 
in WT and TRPC1-/- EDL. (B) Quantification of Fura-2 trace peaks of [Ca2+]i 
after addition of 50 uM AdipoRon to differentiated WT and TRPC1-/- EDL 
myotubes in a Ca2+ buffer. Graphs are mean ± SEM, significance: ***, p < 
0.001. 
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phosphorylation of AMPK, however it was not enough to be significant. Moreover, 
comparison of TRPC1-/- to WT indicated loss of TRPC1 significantly reduced 
phosphorylation of AMPK initiated by AdipoRon treatment (Figure 47 A, B). 
Expression changes of PGC1α	mRNA were next examined and found that loss of 
TRPC1 in EDL myotubes reduced the ability of AdipoRon signaling. Significant 
increases in PGC1α mRNA observed in WT EDL upon AdipoRon treatment were 
not observed in TRPC1-/- EDL (Figure 47 C). The combined results of activation of 
p-AMPK and PGC1α indicates that TRPC1 may be indirectly involved with in the 
function of adiponectin signaling. 
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Figure 46 Loss of TRPC1 in EDL impairs the ability of AdipoRon to 
activate AMPK 
(B) Western blot quantification of ratio of p-AMPK to AMPK in WT and TRPC1-
/- EDL after 5 min treatment with 50 uM AdipoRon n=6, representative blot in 
(A). (C) Relative mRNA expression of PGC1α in WT and TRPC1-/- after 90 min 
treatment with 50 uM AdipoRon quantified by RT-PCR n=6. Graphs are mean 
± SEM, significance: *, p < 0.05, **, p < 0.01; ****, p < 0.0001. 
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Conclusion 
 Within this study our aim was to extend the understanding of Ca2+ 
involvement, specifically SOCE, in adiponectin signaling to determine whether 
decreases in PGC1α expression and other targets in TRPC1-/- muscle are a result 
of decreased signaling capabilities. We employed the use of both the immortalized 
cell line C2C12 and primary EDL skeletal muscle to determine the role of SOCE 
activation due to AdipoR1 activation. Here we are the first to show that AdipoRon 
initiates Ca2+ influx that can be blocked by SKF and 2APB, however these 
treatments do not affect downstream targets. Finally, we were able to determine 
that loss of TRPC1 does not inhibit the influx of Ca2+ due to AdipoRon, but does 
diminish AMPK phosphorylation. Collectively, these results identify SOCE 
involvement in adiponectin, but TRPC1 may not be playing a role.  
 Increased hepatic lipogenesis is a common feature of obesity. Elevated 
expression of both FASN and ACC have been correlated to obesity (Beaven et al., 
2013; Dentin et al., 2006), with the enzyme FASN considered a determinant of 
maximal tissue capacity of lipid storage (Postic and Girard, 2008) and blockage of 
ACC has been shown to reduce excess liver lipid accumulation in mice on a high-
fat diet (Savage et al., 2006). Within our model, the increased expression of FASN 
and ACC observed in TRPC1-/- liver indicates an increase in lipogenesis and could 
be indicative of an obese phenotype. Multiple theories have surfaced as to why 
increased liver lipogenesis is observed in an obese state. These include the 
absence of functional adipocytes resulting in an increase of fatty acids being 
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pushed to the liver (Yki-Järvinen, 2005) and low serum adiponectin concentrations 
negatively affecting liver functionality (Viganò et al., 2011). Further investigation is 
needed to determine the cause of reduced FASN and ACC in TRPC1-/- which could 
be due to dysfunctional adipocytes or liver. 
Muscle is similarly affected by the onset of obesity. Accumulation of lipid in 
skeletal muscle due to high levels of adipose tissue lipolysis or impaired blood lipid 
clearance by adipose tissue is known to result in insulin resistance and 
hyperglycemia in skeletal muscle (Stern et al., 2016). Adiponectin is known to 
offset the negative effects of obesity by encouraging fatty acid oxidation in skeletal 
muscle thereby decreasing intramuscular lipid accumulation and improving insulin 
sensitivity (Civitarese et al., 2006; Fruebis et al., 2001; Yamauchi et al., 2002). 
Similar to adiponectin KO mice (Civitarese et al., 2006), we observed a decrease 
in PGC1α, lipid metabolism, and mitochondrial biogenesis genes in TRPC1-/- 
muscle. This lead us to investigate whether this phenomenon is due to decreased 
circulating adiponectin concentration(s) or decreased adiponectin signaling. 
The small molecule agonist AdipoRon was developed by Okada-Iwabu et 
al. in 2013 which is orally active and binds and activates both AdipoR1 and 
AdipoR2. AdipoRon is known to increase AMPK phosphorylation, PGC1α, and 
mitochondrial content making it a useful tool in studying adiponectin signaling. 
Interestingly, knockdown of AdipoR1/2 or blockage of Ca2+ by EGTA diminishes 
the benefits of AdipoRon in muscle (Okada-Iwabu et al., 2013). Within our study, 
the combination of SKF or 2APB with AdipoRon in C2C12 cells completely 
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abolished the immediate influx of Ca2+ seen in the AdipoRon only cells. However, 
blockage of SOCE currents had no effect on p-AMPK or PGC1α most likely 
indicating a Ca2+ independent mechanism within adiponectin signaling. As seen in 
Figure 41, liver kinase B1 (LKB1) is also known to phosphorylate AMPK and in our 
model, could be compensating for the lack of Ca2+ normally seen. More 
investigation is needed to determine whether LKB1 is compensating for blocked 
Ca2+, however we can determine from our data that SOCE is a partial but not a 
mandatory component of AdipoR1 signaling. 
Examination of WT EDL produced similar results to the C2C12 myotubes 
where SOCE was initiated by treatment with AdipoRon and blocked by SKF and 
2APB. When comparing AdipoRon induced Ca2+ influx in TRPC1-/- to WT EDL, we 
saw no change due to the loss of TRPC1. Importantly, expression in AdipoR1 in 
WT and TRPC1-/- EDL muscle was similar indicating increased or decreased 
binding of AdipoRon to AdipoR1 due to receptor expression changes had no effect 
on the amplitude of Ca2+ influx. This is relevant as muscle and hepatic protein 
levels of AdipoR1 are significantly reduced in obesity (Lustig et al., 2014), further 
indicating that reduced expression of downstream targets of adiponectin signaling 
in TRPC1-/- muscle is due to substrate loss. Interestingly, though there is no 
change in AdipoRon mediated Ca2+ influx due to TRPC1 loss, we did observe 
reduced AMPK phosphorylation. This reduction in AMPK phosphorylation may still 
be linked to loss of TRPC1, however through a different mechanism. Calcium entry 
via TRPCs has been found to be necessary for thrombin-induced nuclear factor 
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kappa-light-chain-enhancer of activated B cells (NF-κB) through AMPK 
phosphorylation in endothelial cells (Bair et al., 2009) which may be relevant to 
muscle function. Whether TRPC1 is linked to the reduced phosphorylation of 
AMPK in our EDL muscle, does not explain how loss of TRPC1 failed to reduce or 
increase PGC1α expression significantly. The evidence of this study suggests that 
TRPC1 does not have a role in AdipoRon mediated SOCE and TRPC1 loss in 
muscle is most likely not the cause of reduced PGC1α, lipid metabolism and 
mitochondrial biogenesis mRNA expression. 
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CHAPTER VII 
DISCUSSION 
 
The role of Ca2+ homeostasis in adipose tissue biology has garnered 
increased attention in recent years due to its connection with metabolic disorders 
(Arruda and Hotamisligil, 2015). The purpose of this dissertation is to expand this 
knowledge base with hopes that the information can someday be used for 
therapeutic interventions. The evidence provided highlights a central role for 
TRPC1 in regulating the Ca2+ dependent processes of differentiation, autophagy, 
and adipokine secretion in adipose tissue.  
TRPC1 and SOCE mechanisms in adipose tissue have recently been 
identified in the 3T3-L1 cell line (El Hachmane et al., 2018; Sukumar et al., 
2012), however no work has been done to confirm this in vivo. The work provided 
here is the first to identify TRPC1 dependent SOCE in primary cell cultures from 
isolated mouse Subc AT and VAT SVF. In both tissue types, it was identified that 
SOCE was present in SVF with TRPC1-like currents and that upon 
differentiation, these currents were amplified with concurrent increases in STIM1 
and TRPC1 protein expression. Genetic ablation of TRPC1 reduced SOCE in 
both Subc AT and VAT SVF and differentiated adipocytes further confirming its 
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role in SOCE. In differentiated VAT, an ORAI1-like current was observed, 
however there was no change in ORAI1 protein expression and ORAI1 was not 
able to compensate for the loss of TRPC1, suggesting that the major Ca2+ entry 
channel in adipocytes is mediated via TRPC1. 
By focusing on adipose tissue function, we’ve identified multiple metabolic 
regulatory functions to be dependent on TRPC1-mediated Ca2+ influx. Herein, it 
was shown that loss of TRPC1 impaired adipocyte differentiation which seems to 
be a result of inhibited PPARy expression. Further, TRPC1-/- animals fed a high-
fat diet and exercised exhibited a reduction in autophagy with a concurrent 
increase in apoptosis. Together these phenomena may be linked as it has been 
shown that a reduction in autophagy impairs adipogenesis (Baerga et al., 2009; 
Singh et al., 2009), however these studies suggest that later transcriptional 
events such as the upregulation of FABP4 and perilipin to be more severely 
impacted by decreased autophagy rather than PPARy in early adipogenesis. 
Overall the data suggests that TRPC1-/- mice have impaired adipogenesis which 
in the long-term may result in hypertrophic obesity, however if the animals are 
stressed through diet and exercise, adipogenesis is further impaired by TRPC1-
mediated reduction in autophagy resulting in apoptosis and fat mass loss. 
The other portion of this dissertation which contributes to the metabolic 
dysfunction due to TRPC1 loss in adipose tissue is the investigation of 
adiponectin secretion. Ex-vivo experimentation of insulin-stimulated adiponectin 
secretion from TRPC1-/- adipose tissue revealed that decreased secretion is 
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likely due to the lack of TRPC1-mediated Ca2+ influx necessary for SNARE 
complex formation and not reduced internal adipose tissue adiponectin stores. 
Further, analysis of serum adiponectin revealed TRPC1-/- mice to have reduced 
concentrations when fed either a high-fat or normal-fat diet as compared to WT. 
Additionally, these same mice had no change in fat mass, blood glucose, insulin, 
or insulin resistance as calculated by HOMA IR. This is contrary to a multitude of 
studies that show a correlation between reduced serum adiponectin 
concentrations and increased fat mass, blood glucose, insulin, and insulin 
resistance typically observed in obesity (Abdelgadir et al., 2013; Berg et al., 
2001; Kou et al., 2018). Together, this data further indicates a non-obesity 
induced reduction in serum adiponectin. Exercise was able to recover serum 
adiponectin concentrations in TRPC1-/- fed either a high-fat or normal-chow diet. 
This may be due to the ability of exercise to increase adiponectin secretion from 
muscle through PPARy activation (Amin et al., 2010) and increased AdipoR1 
expression (Tsuchida et al., 2004; Zeng et al., 2007) thereby bypassing 
dysfunctional adiponectin secretion from adipose tissue. 
Current modeling of adiponectin signaling indicates a direct linkage 
between AdipoR1 activation, Ca2+ influx, and AMPK phosphorylation however 
data from C2C12 cells with blocked SOCE and TRPC1-/- EDL suggests a 
different mechanism. In TRPC1-/- EDL, AdipoRon initiated Ca2+ influx was 
unchanged, however a reduction in AMPK phosphorylation was observed along 
with an inconclusive PGC1α mRNA change. This may indicate an indirect 
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reduction in stimulation or increased inhibition of AMPK due to TRPC1 loss that 
needs to be further researched. This, however, is likely not the cause of the 
significant reduction in PGC1α, FASN, and ACC observed in TRPC1-/- muscle 
and instead is the result of reduced serum adiponectin concentrations.  
In closing, this dissertation efficiently describes the role of TRPC1 in 
modulating critical Ca2+ mediated processes within adipose tissue which in turn 
effects whole body metabolic homeostasis.  
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